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RÉSUMÉ 
La transplantation d’îlots pancréatiques offre un traitement potentielle pour le diabète de type 
1 (T1DM). À ce jour, le succès mitigé de ce type de greffe est dû à plusieurs facteurs limitants 
comme le manque de revascularisation, la perte de la matrice extracellulaire (ECM) et le rejet 
par le système immunitaire du receveur. Dans les dernières années, l’utilisation de matrices 
tridimensionnelles (3D) et de bioréacteurs a amélioré le processus de transplantation et 
approfondi les connaissances sur le sujet. Le but de cette thèse est de mieux comprendre les 
effets des paramètres physiologiques (flux, concentration en oxygène dissous (D.O.) et 
pulsation) sur le tissu pancréatique dans un environnement 3D en utilisant un bioréacteur à 
perfusion. 
Le premier chapitre présente une revue de la littérature détaillant le pancréas, les maladies qui 
lui sont associées ainsi que les techniques permettant son étude in vitro et in vivo. L’utilisation 
de matrices 3D en recherche sur le diabète est discutée en profondeur tout en mettant 
l’emphase sur l’incorporation de molécules de la ECM. La revue souligne comment des 
matrices 3D testées en combinaison avec différents bioréacteurs ont permis de mieux 
comprendre et améliorer la culture de cellules pancréatiques. Une brève conclusion met en 
lumière les applications futures des bioréacteurs dans la recherche sur le diabète. 
La première étude de cette thèse traite de la culture de cellules de rat provenant d’insulinome 
(INS-1), encapsulées dans des matrices de fibrine en chambres de perfusion et cultivées dans 
un bioréacteur à perfusion. Un essai in situ de sécrétion d’insuline stimulée par le glucose fut 
développé pour comprendre les effets de la culture. Dans cette expérience, les effets 
bénéfiques des conditions contrôlées en bioréacteur à perfusion ont été démontrés et ont 
révélé une augmentation de l`indice de stimulation des cellules INS-1 avec le temps, une 
amélioration de la fonction GRIP, en plus d’une incidence moins élevée d’apoptose cellulaire 
en comparaison avec des témoins en culture statique, sans bioréacteur. Cette étude a été 
publiée dans la revue Biotechnology Progress. 
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La deuxième étude décrit un design multifactoriel servant à l’identification des paramètres 
affectant des pancréas de rat dissociés mécaniquement, cultivés dans un bioréacteur à 
perfusion. Les effets uniques et combinés du flux, de la D.O. et de la pulsation ont été étudiés 
sur la culture de tissu pancréatique. Les conditions bénéfiques pour la culture en bioréacteur 
ont été identifiées. Le tissu pancréatique cultivé dans ces conditions bénéfiques a démontré 
une sécrétion d’insuline stimulée par le glucose, une plus grande activité métabolique, une 
coloration positive à l’insuline et au glucagon, des structures endothéliales multiples ainsi 
qu’un tissu plus intact en comparaison avec des cultures statiques cultivées en mode statique. 
Cette étude a été soumise à Biotechnology Progress. 
Mots clés : bioréacteur à perfusion, diabète, sécrétion d’insuline, transplantation d’îlots, 
matrices 3D, culture de tissus pancréatique 
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ABSTRACT 
Transplantation of pancreatic islets offers a potential cure for type 1 diabetes mellitus 
(T1DM). To date, the success of such a graft has been mired by a number of limiting factors 
including lack of revascularisation, loss of native extracellular matrix (ECM), and graft 
rejection by the recipient’s immune system. In recent years, new ways to understand and 
improve this process have been explored using three-dimensional (3D) matrices and 
bioreactors. This thesis aims to further understand the important effect(s) physiological 
parameters (flow, dissolved oxygen concentration (D.O.) and pulsation) have on pancreatic 
tissue in a 3D environment using a perfusion bioreactor with defined geometries.  
 
The first chapter introduces a review of the literature detailing the native pancreas, its diseases, 
and how it is studied in vivo and in vitro. The use of 3D matrices in diabetes research is 
discussed with particular emphasis on the incorporation of ECM molecules. The review then 
highlights how 3D matrices have been used in combination with a host of different bioreactors 
to understand and improve pancreatic cell cultures. A brief conclusion about the future 
applications for the use of bioreactors in diabetes research is also discussed.   
 
The first experimental work comprises the culture of rat insulinoma cells (INS-1) encapsulated 
in fibrin matrices in perfusion chambers and cultured under perfusion bioreactor conditions. 
An in situ glucose-stimulated insulin secretion assay was then developed to monitor the 
culture over time. With this work, the beneficial effects of perfusion bioreactor conditions 
were shown and revealed increasing functionality (glucose-stimulated insulin secretion) of 
INS-1 cells over time, and a lower incidence of apoptosis when compared to static control 
cultures. This study was published in Biotechnology Progress. 
 
The second experimental work used a factorial design to identify process parameters affecting 
whole mechanically-disrupted rat pancreata in a perfusion bioreactor. Here, the singular and 
combinational effects of flow, dissolved oxygen concentration and pulsation were assessed on 
the outcome of pancreatic tissue. Beneficial bioreactor conditions were identified. 
Mechanically-disrupted rat pancreata cultured under these beneficial bioreactor conditions 
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showed glucose-stimulated insulin secretion, higher metabolic activity, insulin- and glucagon-
positive staining, extensive endothelial structures, and overall intact tissue when compared to 
static cultures. This study has been submitted to Biotechnology Progress. 
 
Keywords: Perfusion bioreactor, diabetes, insulin secretion, islet transplantation, 3D matrices, 
pancreatic tissue culture 
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Chapter 1 
 
INTRODUCTION 
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The World Health Organisation (WHO) recently reported that there are over 422 million 
people worldwide suffering from diabetes (WHO, 2016). In Canada, in 2016, the Canadian 
Diabetes Association (CDA) listed a record 3.5 million Canadians as suffering with diabetes 
with an associated healthcare cost of $3.4 billion (CDA, 2016). Between 5 and 7 % of these 
diabetic patients suffer from T1DM (Shapiro et al., 2017). One treatment option offering a 
possible long-term treatment for T1DM is pancreatic islet transplantation. Here, pancreatic 
islets are  mechanically and enzymatically cleaved from a donor pancreas and transplanted 
into the hepatic portal vein of the recipient (Shapiro et al., 2000). However, due to the shortage 
of donor organs this procedure has primarily only been offered to brittle T1DM patients with 
hypoglycemic unawareness. In addition, patients who do undergo this procedure generally 
enjoy insulin-independence for less than 5 years and, thus, require exogenous insulin 
supplements thereafter (Gruessner, 2011; Shapiro et al., 2017). 
 
Some of the limiting factors in the success of the graft include: 1. the need for multiple donor 
organs for a sufficient islet graft, 2. immediate and long-term immune rejection, 3. islet 
damage due to the aggressive nature of isolation (loss of extracellular matrix and mechanical 
damage), and 4. poor revasculatisation post-transplantation (Tatum et al., 2017). 
 
Improving the outcome of islet transplantation has been a particular focus in the diabetes 
research community and there has been a drive to understand the mechanisms that underlie 
graft failure and graft success. Recent tissue engineering approaches to model the mechanisms 
of successful and unsuccessful grafts have focused on culturing encapsulated pancreatic islets 
and insulin-producing β-cells in tridimensional (3D) scaffolds made of biomaterials, using 
different bioreactors. Here, cells are exposed to microenvironments closer to their native ones 
and so are enticed to behave more natively.  
 
This thesis aims to explore the effects important physiological parameters (flow, dissolved 
oxygen concentration and pulsation) have on pancreatic tissue outcome. By exploring and 
understanding these effects, this knowledge could be applied to improve pancreatic islet graft 
outcome by highlighting beneficial pre-culture conditions pre-implantation.  
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In Chapter 2, a review of the literature is introduced detailing the native pancreas, its diseases, 
and how it is studied in vivo and in vitro. The use of 3D matrices in diabetes research is 
discussed at length with important consideration given to the incorporation of ECM 
molecules. The review then highlights how 3D matrices have been used in combination with a 
host of different bioreactors to culture pancreatic tissues and insulin-producing cells with the 
global goal to improve the success of transplanted pancreatic islet grafts.  
 
In Chapter 3, entitled “An in-situ glucose-stimulated insulin secretion assay under perfusion 
bioreactor conditions”, INS-1 cells (a rat insulinoma cell line) were encapsulated in fibrin and 
cultured in a perfusion bioreactor. Briefly, it was found that these cells showed glucose-
stimulated insulin secretion, increasing functionality (glucose-stimulated insulin secretion) and 
lower levels of apoptosis when compared to non-bioreacted 3D and 2D static control cultures.  
  
In Chapter 4, entitled “A factorial design to identify process parameters affecting whole 
mechanically-disrupted rat pancreata in a perfusion bioreactor”; a factorial design was used to 
identify process parameters affecting whole mechanically-disrupted rat pancreata in a 
perfusion bioreactor. The singular and combination effects of flow, dissolved oxygen 
concentration and pulsation were assessed on the outcome of pancreatic tissue. Beneficial 
bioreactor conditions which supported pancreatic tissue attributes were identified. 
Mechanically-disrupted rat pancreata cultured under these beneficial bioreactor conditions 
showed glucose-stimulated insulin secretion, higher metabolic activity, insulin- and glucagon-
positive staining, extensive endothelial structures, and overall intact tissue when compared to 
static cultures.  
 
In Chapter 5, entitled “Conclusion”, the outcome of this thesis is discussed and future 
application and directions are suggested. 
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Chapter 2 
 
INTRODUCTION OF LITERATURE 
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2.1 The pancreas 
The pancreas is located behind the stomach and connected to the liver, the spleen, and the 
small intestine. The main functions of the pancreas are to produce exocrine enzymes to aid 
digestion, and endocrine hormones to regulate blood glucose levels. The exocrine pancreas 
represents approximately 98% of the pancreatic mass and is comprised of acinar cells 
responsible for synthesis, storage and secretion of digestive enzymes (e.g., pancreatic lipase 
and amylase, phospholipase, nucleases) into the duodenum (Jouvet and Estall, 2017). The 
endocrine pancreas represents approximately 2% of the total mass of the pancreas and is made 
up of islets of Langerhans (Hogan and Hull, 2017). These are highly vascularised structures 
that contain 5 distinct cell types; α-, β-, δ-, ε-, and γ (PP) cells. Although the islets of 
Langerhans account for 1-2% of the total mass of the pancreas yet receive 15% of the blood 
flow. This is important in rapidly sensing glucose changes (Jansson et al., 2016).   
 
The main cell population in pancreatic islets are β-cells (50%), which secrete amylin, C-
peptide and, more importantly, insulin. The other main cell type is the α-cell (40%) which is 
responsible for the secretion of glucagon. The small proportion of δ-cells (<10%) and ε-cells 
(<1%) secrete somatostatin and ghrelin, respectively. In addition to the aforementioned cell 
types, PP cells (<5%) are also present and are responsible for producing pancreatic 
polypeptides which acts locally within the pancreas to regulate endocrine function and to 
regulate gastrointestinal secretion (Kojima et al., 2007). Much emphasis has been placed upon 
the hormones insulin and glucagon due to their essential role in the regulation of glucose 
homeostasis. Insulin is produced and secreted by the β-cells in response to glucose although 
insulin is also produced and secreted in response to other non-glucose stimulants and neural 
peptides but to a far lesser degree (Komatsu et al., 2013). Insulin is then released by the β-cells 
into the blood stream and binds to its receptors found on most tissues including the liver, 
muscle and fat cells, to facilitate glucose uptake and storage (Olerud et al., 2011). 
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2.2 Exocrine-endocrine axis 
The endocrine and exocrine components of the pancreas share an anatomical and 
physiological relationship. Pancreatic islets are scattered and embedded throughout the 
exocrine tissue, void of any special capsule or membrane. Given this, it has become 
increasingly evident that these two structures may not be so independent of each other. 
Although the relationship between these two counterparts is still under investigation, the parts 
which are known may give some insight into the special relationship they share.   
In a healthy human adult pancreas, acinar tissue and pancreatic islets are fed separately from 
the pancreatic capillary plexuses which are formed from the major arteries surrounding the 
pancreas. However, the outward flow of blood from the pancreatic islets drains directly into 
the acinar capillary network, aptly named the ‘insulo-acinar axis’ (Evert et al., 2005; Weir and 
Bonner-Weir, 1990). The acinar tissue receives high concentrations of pancreatic islet 
hormones suggesting a possible effect of pancreatic islets on the exocrine pancreas. To date, 
the nature of this effect remains unclear.  
In addition, acinar cells secrete enzymes as zymogen granules into the ducts of the pancreas. 
These secretions are highly viscous and acidic in nature. To counter this, ductal epithelial cells 
secrete alkaline fluid with low viscosity. Furthermore, lithostanthin S, an enzyme which keeps 
the calcium of the pancreatic juice in a soluble state, is present in this secretion. In 
combination, these processes inhibit stone formation within the duct (Chakraborty and 
Chowdhury, 2015).  
 
In the diseased endocrine pancreas, such is the case in type 1 diabetes mellitus (T1DM), the 
effect of chronic hypoinsulinemia causes major functional, morphological, and histological 
changes in the exocrine tissue. These widespread changes include acinar atrophy, fibrosis, 
fatty degeneration, and changes to the ductal system (Ewald et al., 2009; Frier et al., 1976; 
Lankisch et al., 1982; Williams et al., 2012). The exact mechanisms responsible for these 
changes are still under investigation but may be a result of multiple factors including 
inflammation and lack of insulinotropic effects due to the loss of pancreatic β-cells (Campbell-
Thompson et al., 2015).  
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In exocrine pancreatic disorders (for example chronic pancreatitis), increased pancreatic tissue 
pressure and hypoxia have been observed causing alterations to the microcirculation of the 
pancreas. This causes surrounding stellate cells to proliferate and secrete collagen. The net 
result of this is fibrosis of the pancreas which results in a progressive loss of endocrine 
function (Watanabe et al., 2004). In addition, chronically high blood glucose levels have also 
been shown to have a stimulatory effect on stellate cells in the pancreas. This effect may 
increase and amplify the progression of fibrosis in the pancreas (Nomiyama et al., 2007).  
 
It is clear that although this endocrine-exocrine relationship is still not fully understood, the 
research so far highlights the important interplay the endocrine and exocrine may have on 
normal pancreatic function.  
 
2.3 Diabetes mellitus   
Diabetes mellitus (DM) is a broad term used to characterise a group of metabolic diseases. To 
date, it remains a treatable but incurable disease. Diabetes may be subdivided into two main 
types; type 1 (T1DM) and type 2 (T2DM).  
 
In T1DM, pancreatic β-cells are destroyed by the autoimmune system which usually leads to 
absolute insulin deficiency. This autoimmunity is most likely a combination of genetic 
susceptibility and  a host of environmental triggers such as diet, viruses, stress, and exogenous 
toxins (Kuehn et al. 2014b). In a recent study, it was revealed that a host of proinflammatory 
cytokines including interleukin-6 (IL-6), IL17, transforming growth factor-β (TGF-β), C-
reactive protein (CRP), and tumour necrosis factor-α (TNF-α) strongly correlated with disease 
progression (Qiao et al., 2017). However, the exact mechanisms that are responsible for 
causing this inflammation remain unknown.  
Although T1DM makes up just 5-7% of the cohort all diabetes diagnoses, it remains the most 
common endocrine and metabolic condition occurring in childhood (Lysy et al., 2016). 
 
In T2DM, there is a progressive loss of β-cell insulin secretion as a result of chronically high 
blood glucose levels leading to insulin resistance and later insulin deficiency (Katsiki et al., 
2017). This type of diabetes is generally considered to be a result of chronic obesity, low or 
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reduced activity, and poor diet/malnutrition. However, a review of the literature identified 
more than 36 genetic susceptibility factors associated with disease progression (Herder and 
Roden, 2011). 
 
To put this pathology into clinical perspective, the World Health Organisation (WHO) stated 
that there are over 422 million people worldwide suffering from diabetes (WHO, 2016). In 
Canada in 2016, the Canadian Diabetes Association (CDA) listed a record 3.5 million 
Canadians as suffering with diabetes with an associated healthcare cost of $3.4 billion (CDA, 
2016). This is a 76% increase from 2006.  
 
Together, these reports cement the notion that diabetes is of epidemic proportion and new 
ways to diagnose, treat, and understand the pathophysiology of the disease is of great clinical 
and socioeconomic importance.  
 
2.4 Current treatments for T1DM 
2.4.1 Exogenous insulin 
As previously mentioned, T1DM is a treatable but incurable disease. The most common 
treatment deployed by healthcare professionals to patients is exogenous insulin therapy. Here, 
patients monitor their blood glucose levels multiple times daily using a finger-prick test and 
accordingly titrate exogenous insulin, subcutaneously. In general, this method serves the 
insulin-dependent diabetic population with a viable option for transiently correcting blood 
glucose levels. However, this treatment method relies on strict life-time adherence by the 
patient. In addition, insulin is a growth factor and is administered in a non-physiological 
manner. Long-term use of exogenous insulin has been associated with higher incidences of 
cancer, cardiovascular disease, blindness, and peripheral limb amputation (Currie et al., 2009; 
Currie et al., 2013). 
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2.4.2 Whole pancreas transplantation  
Allogenic pancreas transplantation has been considered a treatment option offering a long-
term treatment option for brittle T1DM patients. This is considered major surgery and thus 
carries all of the associated risks. The patient is also required to adhere to a strict life-long 
immunosuppressive medication regime. However, due to the sparse organ donor availability 
and the biocompatability of available donors, just (c.a.) 25,000 transplantations have been 
performed since 1966(Gruessner, 2011). 
 
2.4.3 Pancreatic islet transplantation  
Islet transplantation is much less surgically invasive than whole pancreas transplantation and 
also offers a possible cure for T1DM.  
 
Briefly, the pancreas is surgically excised from the donor. The pancreas is then cannulated, 
treated with collagenase, and mechanically agitated (Ricordi chamber). The resulting islets are 
then purified and transplanted into the portal vein of a recipient. Since the advent of the 
Edmonton protocol, islet isolation and islet procurement have improved significantly resulting 
in a higher viable islet yield and improved clinical outcome. To date, 1500 grafts have been 
performed since its advent in 2000 (Shapiro et al., 2000; Shapiro et al., 2017). However, due 
to the shortage of donor organs, this procedure has primarily only been offered to brittle 
T1DM patients with hypoglycemic unawareness. In addition, patients who do undergo this 
procedure generally enjoy insulin-independence temporarily and, thus, require exogenous 
insulin supplements thereafter. In addition, the patient is required to take life-long 
immunosuppressive drugs (Gruessner, 2011). 
 
Some of the limiting factors in the success of the graft include: 1. the need for multiple donor 
organs for a sufficient islet graft, 2. immediate and long-term immune rejection, 3. islet 
damage due to the aggressive nature of isolation (loss of extracellular matrix and mechanical 
damage), 4. poor revasculatisation post-transplantation (Tatum et al., 2017). 
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Many studies have attempted to understand and improve the clinical outcomes of this 
procedure from the lab bench and in vivo studies alike. Islet transplantation still represents a 
viable and realistic longer-term treatment option for T1DM.  
       
 
2.5 Diabetes research platforms 
2.5.1 Pancreatic islets and β-like cell lines 
Human pancreatic islets isolated from cadaveric donors are the primary cell source approved 
for clinical use, but are limited due to donor availability. Instead, non-human islet sources 
have been investigated as an alternative. To date, researchers have favoured porcine islets as 
an alternative due to their unlimited supply, insulin homology (porcine and human insulin vary 
by just one amino acid) (Dufrane and Gianello 2012), and have been shown to have lower 
sensitivity to destruction by recurrent T1DM autoimmunity than human islets (Koulmanda et 
al., 2003). In addition, porcine islets which have been genetically-modified to reduce 
expression of pro-inflammatory antigens, thus reducing the host immunogenic response, have 
also been explored (Cowan et al., 2016). Furthermore, xenotransplantation studies where adult 
porcine islets were encapsulated in alginate and subcutaneously grafted into non-human 
primates have showed promising clinical outcomes including survival of the graft and 
correction of diabetes without the need for immunosuppression for up to six months post-
transplantation (Dufrane et al., 2010; Marigliano et al., 2011).   
 
Although cell lines have less clinical relevance than islets, they serve as an invaluable tool for 
research purposes due to their ease of handling and abundant availability. β-like cell lines 
come from a host of different species but tend to take their origins from cancer cells (Amer et 
al., 2014). However, their use in developing strategies for tissue engineering approaches is 
supported by their characteristic glucose-stimulated insulin release. Some commonly used cell 
lines used in diabetes research include INS-1 cells (a rat insulinoma cell line) (Asfari et al., 
1992; Sharp and Vermette, 2017), MIN-6 cells (a transgenic mouse insulinoma cell line) 
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(Edén et al., 2015; Ishihara et al., 1993), and β-TC cells (a mouse insulinoma cell line) (Efrat 
et al., 1988; Kim et al., 2015).   
 
2.5.2 Stem cells and their application for T1DM 
Stem cells are undifferentiated cells that can divide and expand, or can differentiate into 
specialised cells such as insulin-producing cells. Insulin-producing cells derived from human 
mesenchymal stem cells (MSCs), embryonic stem cells (hESCs), and induced pluripotent stem 
cells (iPSCs) are a promising treatment for T1DM (van de Vyver, 2017). They continue to 
receive much attention in the diabetes research community because, in principle, large 
numbers of functional cells could be produced and transplanted, therefore, offering a possible 
cure for T1DM. To date, numerous in vivo studies have been performed on small animal 
models. Multiple groups have reported that they can cure or prevent diabetes in mice by 
transplanting insulin-producing cells derived from stem cells in cell numbers ranging from 
1.25 to 7 x 106 (D’Amour et al., 2006; Espes et al., 2017; Kroon et al., 2008; Pagliuca et al., 
2014; Rezania et al., 2014). More recently, islet-sized ‘neo-islets’ were produced by 
aggregating pancreatic islet cells (β- and α-cells) with MSCs and transplanted these into the 
peritoneal space of mice. These mice achieved long-term glyceamic control without the need 
for immunosuppression (Westenfelder et al., 2017). In another recent study, hESC-derived 
pancreatic endoderm cells were transplanted into diabetic mice in a prevascularised 
subcutaneous site. These cells were able to correct long-term hyperglyceamia by secreting 
insulin in glucose-regulated manner (Pepper et al., 2017).  
 
One promising outlook for the treatment of T1DM in humans has come from ViaCyte; a 
company specialising in the induction/derivation of PSCs into pancreatic β-cells. Here, PSCs 
are induced/differentiated into progenitor pancreatic β-cells. These cells are then encapsulated 
in a flat immune-evading capsule and then transplanted subcutaneously into the patient. The 
progenitor β-cells then mature into insulin-producing β-cells in vivo. This approach has 
successfully corrected hyperglyceamia in rat and mice models (Lee et al., 2009; Pagliuca et 
al., 2014). These cells combined with this technology have now entered Phase I-II clinical 
trials in humans (Trounson and DeWitt, 2016).       
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Although the current perspective for use of stems cells in the treatment of T1DM cannot be 
dismissed, there are some special considerations to be noted. In addition, murine studies have 
reported the formation of teratomas when hESCs were transplanted (Kelly et al., 2011; Kroon 
et al., 2008).      
 
2.5.3 3D static systems  
To date, the majority of cell-based assays use traditional two-dimensional (2D) monolayer 
cells cultured on flat and rigid surfaces made primarily of glass or tissue culture polystyrene 
(TCPS). This method has proven to be a valuable tool for cell-based studies, however, its 
limitations have increasingly become recognised. Since almost all cells in the in vivo 
environment are surrounded by other cells and by ECM in a three-dimensional (3D), 2D cell 
cultures do not adequately take into account the natural 3D microenvironment of cells. 
 
In 2D systems, cells are plated as monolayers and receive a heterogenous supply of nutrients 
and oxygen from the medium reservoir. Cellular waste products are also secreted and remain 
in the medium reservoir. Dying cells detach and are washed away during medium change. The 
remaining cells are normally flat and have a restricted cell morphology to planar geometries 
that inhibit the formation of more complex tissue architecture, unlike their native environment. 
Additionally, concentration gradients often form which can effect cellular behaviour 
(Edmondson et al., 2014; Tibbitt and Anseth, 2012). 
  
It has repeatedly been demonstrated that cells that are exposed to a 3D environment with and 
without the addition of ECM cues show large differences when compared to those in 2D 
systems. These studies have reported increased viability, increased proliferation, and more 
dynamic morphology alike to their native environment (Hanjaya-Putra et al., 2011; Lewis et 
al., 2015; Mori et al., 2009; Zhu et al., 2017).  
 
Given this, there has been a surge in 3D matrix design for the intention of cell culture 
applications. 
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2.6 Extracellular matrix molecules in the native pancreas  
Multiple researchers have reported the merits of using extracellular matrix molecules in the 
design of 3D matrices for research purposes.  
 
The ECM is made of a basement membrane (BM) and of an interstitial ECM. The BM is 
organ-specific meaning its structure, composition, and function varies. It separates the 
epithelial and endothelial tissue from the connective tissue and is generally made up of 
laminin, microfibrils, fibronectin, laminin, and different collagens. Generally, these are 
glycoproteins and fibrous proteins that provide the 3D structural support, and cell adhesion, 
and they have been shown to activate intracellular signalling pathways (Daoud et al., 2011; 
Kuehn et al., 2014b; Stendahl et al., 2009).  
The interstitial ECM is highly varied and is generally composed of structural proteins and of 
polysaccharide chains of glycosaminoglycans (GAGs) which interact with proteins to form 
proteoglycans (Palombo et al., 2014). 
 
To date, the exact composition and arrangement of the pancreatic ECM is still under 
investigation and little is known about ECM homology across species. However, some studies 
have identified important components present including laminins and collagens, and heparan 
sulfate proteoglycan (HSPG) families providing binding and interaction sites with integrins 
(Cross et al., 2017; Wang and Rosenberg, 1999a).    
Most recently, our group has reported some advances in the identification of native ECM 
molecules within the pancreata of mice and pigs. Briefly, our group used scanning electron 
microscopy, proteomics, and immunohistochemistry to identify the presence and location of 
some important ECM molecules from decellularised matrices. In mice, they showed that the 
α4 and β2 chains of laminin were localised inside the islet but were absent around the islet 
when the islets were surrounded by an ECM made of collagen IV and V. In addition, collagen 
type I, III, and VI were identified in pig pancreatic ECM. Isoforms of collagen type IV and 
type V were also present, however, in a much lower abundance (Vigier et al., 2017).   
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As mentioned previously, in addition to offering biochemical cues to mediate cell behaviour, 
the ECM is also, at least in part, responsible for maintaining the 3D structure of the islet. 
These findings are reinforced when considering the poor clinical outcome of islets 
transplanted in T1DM patients. During islet isolation, much of the ECM is lost due to the 
isolation technique and some researchers have attributed this to be one of the main factors for 
the poor clinical outcome of transplanted islets (Davis et al., 2012; Nagata et al., 2001).  
 
In light of this, researchers have used 3D scaffolds made of biomaterials, and more 
specifically, hydrogels, in an attempt to replicate the native 3D microenvironment of the cell 
with their native ECM molecules. 
 
2.7 Biomaterials - 3D hydrogel matrices   
2.7.1 Fibrin  
Fibrin is a soluble, fibrous, transient ECM, FDA-approved protein formed at the site of 
vascular injury by the polymerisation of fibrinogen by the protease thrombin (Laurens et al., 
2006; Mosesson, 2005). More importantly, fibrin contains the Arg-Gly-Asp (RGD) amino acid 
sequence which is a ligand for 24 known integrin receptors (Arnaout et al., 2005; Riopel et al., 
2015). In an in vitro setting, fibrinogen has been purified from a host of species and 
crosslinked with thrombin to form hydrogels which enable encapsulation of both pancreatic 
islets and pancreatic β-cell lines. In the context of pancreatic islet transplantation, fibrin has 
shown potential for improving islet viability, function, and preservation of native islet 
morphology (Andrades et al., 2007; Beattie et al., 2002a; Kidszun et al., 2006; Kim et al., 
2012; Lim et al., 2009; Maillard et al., 2011). We have previously shown that encapsulation of 
young porcine islets in fibrin matrices had a significantly positive protective effect against 
apoptotic stimuli (hydrogen peroxide) (Kuehn et al., 2014a). More recently, we showed that 
INS-1 cells (a rat insulinoma β cell line) encapsulated in fibrin matrices exhibited improved 
functionality and lower levels of apoptosis when compared to INS-1 cells plated on TCPS 
(Sharp and Vermette, 2017). In another study, INS-1 cells cultured within and on fibrin using 
2D and 3D culture techniques showed improved glucose-stimulated insulin secretion, formed 
islet-like clusters, and showed increased αvβ3 protein expression; a major ligand for RGD 
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(Riopel et al., 2013). In another study, porcine islets were embedded in fibrin matrices and 
cultured for 7 days in a traditional cell culture incubator. Here, the islets dissociated in fibrin 
over time (Dubiel et al., 2014).   
 
Given this, it has been proposed that purifying fibrinogen from a human islet graft recipient’s 
blood could both improve the quality of the islet graft and reduce the intensity of the 
immediate immune response post-transplantation in humans. 
 
2.7.2 Collagen 
Hydrogels which incorporate different collagens are gaining widespread popularity as 
scaffolds for tissue engineering due to the abundance of collagen in native extracellular matrix 
(ECM). Briefly, collagen comprises 25% (by dry weight) of total structural protein in vivo 
(Antoine et al., 2014; Drury and Mooney, 2003). The aforementioned collagens I, V, and VI 
are the most abundant isoforms within the islet-exocrine interface of the developed human 
pancreas (Di Lullo et al., 2002). Collagen IV appears less abundantly in the mature pancreas 
but is strongly expressed in foetal pancreatic tissue (Cirulli et al., 2000).  
It has previously been shown that rat islets plated on TCPS plates coated with collagen I or IV, 
remained 60% and 89% viable, respectively. In contrast, over 90% of rat islets left in 
suspension underwent apoptosis after 48h (Pinkse et al., 2006). 
 
In another study, murine islets embedded in 3D collagen matrices significantly improved graft 
survival post-transplantation. Here, chronic hyperglyceamia was corrected and less islets were 
required to correct the hyperglyceamia compared to non-collagen support controls (Jalili et al., 
2011). Further, transplanted collagen IV-adsorbed 3D scaffolds containing mouse islets 
significantly improved glycemic control faster than scaffolds coated with either fibronectin, 
laminin, or serum (Salvay et al., 2008). 
 
More recently, human islets have been microencapsulated in collagen IV-reinforced alginate 
matrices and showed improved glucose-stimulated insulin secretion and improved basal 
insulin secretion when compared to islets encapsulated in alginate matrices alone. 
Interestingly, this effect was concentration-dependent, where the lowest concentration of 
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collagen IV used showed the largest effect. This may mimic the native in vivo conditions of 
the mature human pancreas where collagen IV is in low abundance (Llacua et al., 2016).  
 
2.7.3 Alginate  
Alginate is an unbranched, anionic polysaccharide made from repeating units of α-L-
guluronate (G) and β-D-mannuronate (M) and is found in the cell walls of brown algae. 
Historically, it has been a major candidate for use as a biomaterial as it is noted for exhibiting 
a low immunogenic proﬁle, has a non-toxic effect, and can undergo sol-gel transition under 
physiological conditions (Amer et al., 2014; Strand et al., 2003; Strand et al., 2017).  
 
Alginate beads/matrices can be easily manipulated by the researcher and are formed by 
dripping an alginate solution containing  G-, and M-, and GM-monomers/polymers of various 
lengths into a calcium dihydrate solution. The properties of the alginate beads are determined 
by the length and conformation of the resulting polymers, thus, each bead may contain a 
different ratio of G-, M-, and GM-monomers/polymers (Martinsen et al., 1989).  
 
As cells do not have receptors that recognise alginate, it may be considered an inert 
compound, thus, some researchers have chosen to supplement alginate with other ECM 
molecules to entice cellular behaviour (Andersen et al., 2015). Given this, one of the main 
research goals for encapsulation of islets in alginate has been to circumvent the problems 
associated with the immediate and long-term immune responses by the host upon islet 
transplantation by creating an alginate ‘shield’. The use of alginate encapsulation may evade 
the need for the lifelong immunosuppression regime required post-transplantation (both of 
these severely impact the clinical outcome of the graft) (Strand et al., 2001).  
 
To date, there are few recent studies detailing the application of alginate-encapsulated islets in 
the treatment of humans with T1DM. One study followed up 4 patients who had alginate-
encapsulated islets grafted into their portal vein, 3 years post-transplantation. Here, all 4 
patients showed reduced immune responses to the graft when compared to non-encapsulated 
islet grafts. In addition, all patients showed a basal and stimulatory response from glucose 
(serum C-peptide). However, none of the patients ever achieved insulin independence and 
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only one patient was able to transiently reduce  exogenous insulin intake (Basta et al., 2011). 
This finding confirmed the results of a previous study. Here, rat islets were encapsulated in 
purified alginate. These islets were then transplanted into the microcapsules in the peritoneal 
cavity of diabetic rats for up to 12 months. Glyceamic control was achieved within 5 days 
post-transplantation but hyperglyceamia reoccurred within 6-20 weeks post-transplantation. 
Interestingly, purified alginate-encapsulated islets showed a higher biocompatibility and, thus, 
lower immune responses compared to non-purified alginate-encapsulated islet grafts and free 
non-encapsulated islet grafts (De Vos et al., 1997). 
 
In another study, human islets were encapsulated in alginate (500 µm diameter) and 
transplanted into the abdominal cavity of 10 non-immunosuppressed T1DM human patients. 
Here, all participants showed improved glyceamic control however none of the participants 
were ever able to achieve insulin-independence (Calafiore et al., 2006). In another large 
mammal study, pig islets were macroencapsulated in alginate and transplanted these 
macrocapsules subcutaneously in T1DM-induced primates. Here, diabetes was corrected 
(insulin-independent) for up to 6 months. Interestingly, a strong humoral response was 
observed post-transplantation in these primates however the physical properties of the alginate 
capsules prevented diffusion of IgG into the graft for up to 20 weeks (Dufrane et al., 2010). 
This suggests that the composition of the alginate, in this case 3% wt/vol was used, should be 
an important consideration when encapsulating islets for transplantation with a goal of evading 
the immune system.          
 
In 2007, a brief communication was published describing a T1DM patient who received a 
transplantation of alginate-encapsulated porcine islets. The patient was then followed up for 
18 years. Although the patient never achieved insulin-independence, a marked decrease in his 
exogenous insulin supplement was needed to achieve euglygeamia. The graft remained 
functional for 18 years. This study highlights both the possible use of alginate as an 
encapsulation matrix and the use of porcine islets as a surrogate to treat T1DM (Elliott et al., 
2007).  
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In another study, alginate-encapsulated human pancreatic cells were grafted into the peritoneal 
cavity of totally immunocompromised diabetic mice. The grafts exhibited rapid secretory 
responses to glucose and glucagon after 5 weeks. Free grafts (non-alginate-encapsulated 
pancreatic cells) showed reduced function, reduced viability, and a higher incidence of 
necrosis over the same period of time (Jacobs-Tulleneers-Thevissen et al., 2013).  
    
These findings may still suggest an important role for alginate to evade the destructive nature 
of the immune response on the graft. These findings also suggest that alginate in combination 
with another ECM molecule may yield a better clinical outcome (insulin independence).  
 
Together, these studies highlight the positive clinical effects alginate encapsulation may 
potentially have on islet graft outcome. However, it is noteworthy to mention that ion-
exchange (with sodium) and chelating ions such as phosphates make alginate beads 
susceptible to destabilisation by depletion of calcium ions under physiological conditions thus 
creating a major barrier for longer-term culture periods (Morch et al., 2007). Using Ba2+ or 
Sr2+ as chelating ions have been shown to produce stronger, yet still biocompatible alginate 
gels (Morch et al., 2006). An alternative mechanism to achieve alginate gelation is to 
covalently cross-link alginate using photo cross-linking. Briefly, alginate can be mixed with 
methacrylate and cross-linking can be achieved using an argon ion laser. This method has 
been used to seal corneal perforations indicating that this method may be a suitable candidate 
for other tissue engineering applications. The rate of degradation is slower compared to ion-
exchange preparations of alginate (Smeds et al., 2001).       
 
2.8 Three-dimensional matrices limitations 
As reported, the beneficial effects of using 3D hydrogels give cells a 3D microenvironment 
and so encourage cells to behave more natively. However, static 3D cell and tissue culture 
systems also have a host of limitations. For example, there is no mixing or circulation of the 
culture medium which causes heterogeneous distributions of nutrients and metabolites causing 
concentration gradients (Tibbitt and Anseth, 2009). In addition, the dimensions of the 
matrix/scaffold should be an important consideration. In the native cell environment, cell-
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capillary distances range from 20 to 200 µm (Volkmer et al., 2008). The capillaries assist the 
cells in nutrient and oxygen acquisition and in the removal of cellular waste products. Due to 
poor oxygen diffusivity in aqueous solutions, oxygen diffusion in in vitro systems is limited to 
a distance of 100 –200 µm (Carrier et al., 2002; Lovett et al., 2009). Recently, it has been 
demonstrated that cells which reside at the base of the matrix (furthest from the oxygen 
source) undergo hypoxic changes and ultimately cell death (DelNero et al., 2015).  
 
Accurate quantification of these systems also remains a challenge. For example, researchers 
have favoured quantifying the secreted protein of interest from the medium reservoir which 
lies on top of the 3D matrix construct (Carriel et al., 2012; Sodian et al., 2002a). This method 
may negate the accumulated protein that remains within the matrix. Our group has previously 
demonstrated that disproportionate amounts of proteins remain within the matrices (Kuehn et 
al., 2013; Sharp and Vermette, 2017). Efforts to quantify the remaining protein in the matrix 
by dismantling/degrading the matrix using digestive enzymes have been unsuccessful. It was 
found that digestive enzymes also affect cells within the matrix, which can cause cell damage 
and even cell death, thus, preventing an accurate quantiﬁcation of the culture (Sabra and 
Vermette, 2011).   
 
Imaging 3D cultures in situ also remains a challenge. Normal bright-field and fluorescent 
microscopy is hindered by the dimensions of the matrix/construct. Instead, more advanced 
imaging techniques are required including confocal microscopy, magnetic resonance imaging 
(MRI), positron emission tomography (PET), and computed tomography (CT).  
   
In combination, these limitations have grave implications for higher cell seeding densities, size 
of construct, and are limiting factors in the scale-up of in vitro 3D cell culture systems.  
 
Given these challenges, researchers have refocused their efforts to create more dynamic 3D 
systems which improve oxygen and nutrient delivery, removal of cellular waste products, and 
homogeneity of cultures. The use of bioreactors in combination with cell-containing 3D 
matrices may circumvent these challenges.     
 
 20 
 
2.9 Bioreactors 
In the realms of research, the word bioreactor is a broad term used to describe a system in 
which an extra-cellular device is added to a cell or tissue culture system that can closely assist, 
monitor, and tightly control environmental and operating conditions including flow, 
temperature, pressure, pH, pulsation etc. (Martin et al., 2004). Biorectors are used to 
circumvent the aforementioned limitations of static 3D culture systems and help in furthering 
our understanding of how cells behave in vivo by more closely replicating the native in vivo 
environment more than the capabilities of static 3D culture systems.  
 
In addition to their widespread use in an industrial setting, bioreactors have also been widely 
used in tissue engineering areas such as bone engineering, cardiac regeneration, and tumour 
modelling. To date, the use of bioreactors in the field of diabetes research remains an 
emerging field with some important advances having being made using a host of different 
bioreactors.  
 
2.10 Bioreactors in diabetes research 
2.10.1 Spinner flask 
A spinner flask reactor is a variation of a constantly stirred-tank reactor (CSTR) (Bijonowski 
et al., 2013). To counter the problems associated with low seeding efficiency and other 
limitations present in static culture systems, spinner flask bioreactors offer convective flow 
and produce hydrodynamic forces that attempt to increase mass transport in a given culture 
(Gaspar et al., 2012). They come in a host of simple designs but are generally composed of a 
cylindrical container complete with an inlet/outlet port for introduction or removal of cells and 
medium. They also contain a basal stirring element to allow constant mixing of culture 
medium and oxygen, thus, reducing the boundary layer formation at the cell-medium interface 
(Yeatts and Fisher, 2011). Cell cultures can be suspended without a matrix or in a 
scaffold/matrix which is normally suspended in a fixed position and anchored to the top of the 
cylindrical container (Martin and Vermette, 2005a).  
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Spinner bioreactors have been used extensively in bone tissue applications but little is known 
on the effects these bioreactors have on pancreatic tissue. In one of the few studies on such a 
system for pancreatic applications, Chawla et al. (2006) inoculated spinner bioreactors with 
collagenase-dissociated pancreatic porcine neonatal tissue. The inoculated spinner bioreactors 
were then placed into a traditional cell culture incubator and cultured for 9 days. The effects of 
serum-free medium and pH were also investigated. The pH was manually adjusted. The results 
showed that dissociated neonatal pancreatic porcine tissue reformed into aggregates, showed 
massive cellular proliferation (7.5 times increase), and exhibited glucose-responsive behaviour 
at pH 7.3 (Chawla et al., 2006). Aforementioned, these systems are simple in design and so 
lack the ability for automation (automatic control of pH, temperature, and dissolved oxygen 
concentration) creating a barrier for the researcher using more complex tissue types.  
 
2.10.2 Rotating wall vessel bioreactors   
The rotating wall vessel (RWV) was first developed by NASA to create a microgravity 
environment (Wong, 1997). Principally, these reactors are composed of two cylinders (one 
encased in the other) where the inner cylinder is static and has a porous wall used for gas 
exchange (Varley et al., 2017). The outer cylinder is the rotating vessel for the medium 
containing cells/tissue. The cells/tissues normally require a supporting matrix such as a 
collagen or alginate hydrogel. These cell/tissue constructs are then added to the medium in the 
outer cylinder and are suspended in a simulated zero gravity state achieved by rotating the 
vessel (Begley and Kleis, 2002). RWVs exhibit low shear stress and turbulence on the 
cell/tissue culture. In addition, the researcher is able to control the gas exchange in the system. 
In combination, these are major advantages when comparing RWV to CSTR systems (Martin 
and Vermette, 2005a).  
 
In some of the first studies to use this technology, it was observed that cells aggregated and 
tissue-like spheroids formed highlighting its potential for a host of tissue engineering 
applications, especially its use in the study of diabetes (pancreatic islets are essentially 
aggregates/spheroids) (Granet et al. 1998; Manley & Lelkes 2006).   
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In a recent study, Samuelson and Gerber (2013) cultured murine pancreatic β-cells (β-TC-6 
cells) on collagen beads in a RWV for 2 weeks. RWV cultures showed the formation of islet-
like clusters, robust proliferation, enhanced transcriptional signalling, improved translation of 
pancreatic genes, and markedly higher glucose stimulated insulin secretion compared with 
two-dimensional static culture (Samuelson and Gerber, 2013).    
 
In another study, Tanaka et al. (2013) cultured MIN6 cells in a RWV to produce 250 µm 
spheroids. These spheroids showed increased upregulation of several β-cell genes (including 
insulin 1, insulin 2, and glucokinase genes) compared to non-spheroid 2D MIN6 cells cultured 
on TCPS. The spheroids also showed increased insulin secretion upon glucose stimulation. In 
addition, the researchers then transplanted these spheroids into the portal vein of 
streptozotocin-induced diabetic mice for 30 days. They reported that the spheroids corrected 
hyperglyceamia in a series of glucose challenges compared to non-spheroid MIN6 cell 
transplants. 
In combination, these studies support previous documented observations on the use of RWV 
in the culture of pancreatic cells (Rutzky et al., 2002; Stepkowski et al., 2006; Wong, 1997).  
 
The positive applications for the use of RWVs in spheroid production have been described, 
however, due to the low shear stress and turbulence exhibited by this system, culturing more 
complex tissues, where shear has been shown to have a negative effect on tissue outcome, may 
hinder their use.    
 
2.10.3 Perfusion bioreactors 
The importance of pancreatic perfusion has been well documented in the literature in animal 
models. Briefly, it has been repeatedly demonstrated that there is decreased pancreatic 
perfusion in T1DM-induced animals of different species when compared to their healthy 
counterparts (Jansson and Hellerstrom, 1983; Lifson et al., 1980; Nyman et al., 2010). More 
recently however, positive electron tomography (PET) was used to highlight the disparity in 
pancreatic perfusion in T1DM humans. Here, it was shown total pancreatic perfusion was on 
average 23% lower in individuals with T1DM under fasting conditions compared to sex-, age-, 
and BMI-matched healthy control individuals. Upon glucose-stimulation, there was a 48% 
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higher pancreatic perfusion in healthy individuals compared to the T1DM cohort (Carlbom et 
al., 2016). In combination, these studies highlight the important role perfusion may play in 
pancreas homeostasis. 
  
Unlike RWV or CSTR systems, perfusion bioreactors can provide more uniform mixing of the 
medium, thus, allowing for better environmental control and physical stimulation of cells in 
larger cell or tissue constructs. In addition, they use flow to perfuse medium through the 
construct (Wang et al., 2015).   
 
In general, the design of a perfusion reactor is fairly constant, consisting of a peristaltic pump, 
a culture medium vessel, tubing to complete the circuit, and a cell-, or, tissue-containing 
perfusion chamber (Gaspar et al., 2012; Tapia et al., 2016). There are many different 
variations of perfusion chambers, thus, this is normally the main differentiating factor amongst 
perfusion bioreactors. However, more recently additions such as gas exchange units and 
pressure transducers have been added.. Given this, perfusion bioreactor systems are sometimes 
referred to as ‘dynamic’ systems as they can allow the researcher to test a range of 
physiological parameters in unison on a given cell or tissue culture; a major advantage over 
other bioreactor systems. Some of these parameters are flow rate, dissolved oxygen 
concentration, pulsation, temperature, pH, and pressure.   
 
In one of the few studies using a perfusion bioreactor with human islets, human islets were 
successfully dedifferentiated  into proliferative duct-like structures (DLS). Here, they 
encapsulated human pancreatic islets in collagen-fibronectin matrices and further encased 
these in a 3D-printed poly(DL-lactide-co-glycolide) scaffold. They then incorporated these 
scaffolds into a perfusion bioreactor with dielectric spectroscopy capabilities. The scaffolds 
were then perfused with medium. Dielectric spectroscopy measurements were taken over the 
culture period (9 days) and the  spectra were successfully assigned to the different stages of 
dedifferentiation into DLS (Daoud et al., 2015). This study highlights the benefits of using a 
perfusion bioreactor to monitor a culture over time with little or no invasive techniques. To my 
knowledge, this is the only published study on the use of a perfusion bioreactor for culturing 
human pancreatic islets. 
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In my own study, INS-1 cells (rat insulinoma β-cells) were encapsulated in fibrin matrices 
inside a hollow-fibre perfusion chamber and cultured using a proportionally-, and integrally- 
controlled (PI) perfusion bioreactor. Here, set points for temperature, dissolved oxygen, and 
pH were selected and stringently controlled using the PI system. In addition, cells were also 
exposed to flow using a peristaltic pump.  After a 48h culture period, the cells were then 
glucose challenged and compared to non-bioreactored cultures prepared in the same way. 
Bioreacted cultures showed improved glucose-stimulated insulin secretion and a lower 
incidence of apoptosis compared to non-bioreacted cultures 3D static cultures (Sharp and 
Vermette, 2017). 
 
Aforementioned, the use of perfusion bioreactor cultures for diabetes applications is currently 
under-represented in the literature. However, the effect(s) of flow have also been investigated 
in other bioreactor systems. For example, Sankar et al. (2011) used a microfluidic device to 
demonstrate that direct flow on free pancreatic mouse islets dampened insulin-secreting β-cell 
function at the periphery of the islet (those cells directly exposed to shear) compared to cells 
closer to the core. 
Another study has reported the effect(s) of pulsatile flow on the pancreas. Lesser et al. (2004) 
showed that a higher viable and functional yield of human islets for transplantation was 
obtained when the surgically-removed pancreata, from heart-beating donors, were exposed to 
pulsatile flow compared to those that were not. However, the exact mechanism that governs 
this finding has yet to be identified.      
 
In conclusion, perfusion bioreactors offer diabetes research a currently under-explored and 
exciting approach for the culture of pancreatic tissue.   
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2.11 Bioreactor Limitations  
2.11.1 Sterilisation 
Bioreactor sterilisation is one of the most important considerations of any upstream and 
downstream biotechnology process. Sterilisation should not be underestimated and a large 
portion of the work in this thesis involved optimising the sterilisation process so mammalian 
cells could be used in a bioreactor system without contamination. Detailed descriptions of the 
bioreactor sterilisation process used in this thesis are found in chapters 3 and 4. 
 
Common contaminants include bacteria, viruses, and yeast (Hu et al., 2015). In 2010, the FDA 
investigated two major cases of bacterial contamination. One case involved contamination of a 
fermenter used in the manufacture of a protein product secreted by a bacterial host. The 
contaminant was identified as Bacillus cereus, a Gram-positive spore-forming bacterium. A 
second case involved the contamination of a fermenter used in the manufacture of a 
recombinant protein by Paenibacillus curdlanolyticus, a Gram-variable, spore-forming 
Bacillus species (Suvarna et al., 2011). The overall cost of these contaminations (including 
total recall of products, fines, loss of materials, investigation costs, and legal costs) were 
estimated to exceed US$ 3.7 billion. Contamination can be time-consuming with a high 
economic penalty.  
 
Current techniques employed to sterilise bioreactor systems at the small-scale include:  
1. Thermal  
2. Chemical  
3. Radiation  
4. Filtration      
 
For FDA approval, all sterilisation methods must meet the requirements set by the 
International Organization for Standardization (ISO). Here, the ISO give strict guidelines on 
how a device should be sterilised:   
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Thermal sterilisation: can be subdivided into two main catagories; 1) Dry heat sterilisation, 2) 
Moist heat sterilisation: 
  
1) Dry heat sterilisation can be achieved using an autoclave or large-scale oven. It is the 
most economical method in the heat sterilisation category. Principally, the degradation 
and subsequent death of microorganisms is a function of the time-temperature 
combination. This method requires higher temperatures and longer exposure times to 
achieve the efficiency of microbial-killing when compared to steam sterilisation. One 
of the main problems associated with dry heat sterilisation is non uniform distribution 
of temperature. Furthermore, dry heat cannot be used with bioreactor materials that are 
heat sensitive. 
The ISO recommendations for dry heat sterilisation are as follows (ISO 17665-1:2006 
Dry Heat Sterilization Method): 
- A minimum of 180oC for not less than 30 minutes. 
- A minimum of 170oC for not less than 1 hour. 
- A minimum of 160oC for not less than 2 hours.    
 
2) Moist heat sterilisation refers to the exertion of saturated steam under pressure 
achieved using an autoclave. This method of heat sterilisation is more efficient than 
dry heat sterilisation because heat exchange by steam is more rapid than by dry heat 
(Moesby et al., 2005). Bacterial death by moist heat sterilisation is due to denaturation 
and coagulation of essential protein molecules and cell constituents (Pelczar and Krieg, 
1993). Bioreactor materials should be heat resident greater than 121oC. The ISO state 
that to achieve moist heat sterilisation the heating conditions are as follows (ISO 
17665-1:2006 Moist Heat/Steam Sterilization Method): 
- Pressure of 15 lb/ per square inch (psi) 
- Temperature of 121oC 
- Minimum time of heating for 15 minutes at the specified temperature and pressure   
 
Chemical sterilisation:  A number of different FDA-approved chemicals can be used for 
sterilisation of bioreactor. These include (ISO 11135-1:2007 Chemical Sterilization Method):  
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1) Ethylene oxide – Acts by alkylation to kill microorganisms (Shintani, 2017) 
2) Activated alkaline glutaraldehyde – an antimicrobial and sporicidal detergent. These 
solutions are non-corrosive to metals and plastics, and can be easily rinsed away with 
water making them an attractive option for chemical sterilisation of biorectors (Hut et 
al., 2017) 
3) Alcohol – Alcohols (ethyl alcohol, isopropyl alcohol, and propanol) exhibit rapid 
broad‑spectrum antimicrobial activity against bacteria (including mycobacteria), fungi, and 
viruses but they lack sporicidal activity thus additional sterilisation techniques are required 
(Ganavadiya et al., 2014) 
Radiation Sterilisation: Gamma and E-Beam radiation-based sterilisation using radionuclides 
60 Co and 137 Cs, and to irradiators using a beam from electron or an x-ray generator (ISO 
11137-1:2012 Radiation/Gamma Ray Method) 
 
Filtration: - membrane filters with small pores (0.44 and 0.22 µm diameters). The filtration 
sterilisation is usually used for sterilisation of liquids pertaining to the bioreactor (e.g. culture 
medium). Inert materials such as polyethersulfone are used (ISO 13408-2:2003 Filtration 
Sterilization Method).       
 
2.11.2 Quantifying and imaging of 3D cultures in bioreactor systems   
Imaging cultures under bioreactor conditions in 3D matrices remains a barrier. Alike to the 
limitations of static 3D matrices, imaging is dependent on the geometries of the scaffold. 
Normal bright field microscopy is often difficult and the quality of these images are often 
poor. Instead, more advanced imaging techniques are required including confocal microscopy, 
MRI, PET, and (CT).   
Quantification remains a challenge also. However, bioreactors often have built-in sampling 
ports which allow the researcher to sample circulating or agitating medium. In flow systems, 
for example, the 3D matrix is perfused and so there are little or no concentration gradients 
within the matrix, thus, sampling circulating medium is beneficial to quantify total cellular 
protein secretion. This is another merit to using a bioreactor for the purpose of mammalian or 
tissue cell culture in 3D matrices.  
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2.12 Conclusion 
I have attempted to give a summary of the native pancreas, its diseases, and how we study 
those diseases in tissue engineering using biomaterials and bioreactors. Islet transplantation 
still offers the potential for a viable cure for T1DM. However, more information is required to 
understand the mechanisms that govern the success of such a graft.  
To date, the use of bioreactors in diabetes research is underrepresented in the literature. 
Bioreactor systems offer the researcher the ability to test important physiological parameters 
on cells/tissue in a controlled environment void of complexities such as the immune system 
response. The studies that have been performed so far have shown many promising results. It 
has been demonstrated that pancreatic β-cells (free or in their native islet form) encapsulated 
in a 3D matrix with ECM cues, and cultured in a dynamic environment (in vivo or under 
bioreactor conditions) show improved function and behave more natively when compared to 
2D and 3D static culture systems. The applications for this are endless. For example, this may 
mean that bioreactors could be used for pre-culture of islets or whole pancreas prior to 
implantation. This could lead to a higher functional yield of the graft by circumventing 
transport limitations. In addition, a bioreactor could be used to co-culture recipient endothelial 
cells and donor islets pre-transplantation. This may reduce the initial response by the host 
immune system upon transplantation. This may also assist in the revascularisation process 
upon transplantation.     
Although more work is required to improve quantification of these systems, bioreactors and 
3D matrices remain an exciting frontier for tissue engineering research. 
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Chapter 3 
 
AN IN-SITU GLUCOSE-STIMULATED INSULIN 
SECRETION ASSAY UNDER PERFUSION 
BIOREACTOR CONDITIONS  
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Titre en français :  
Un essai in-situ de sécrétion d'insuline stimulée par le glucose sous des conditions de 
bioréacteur à perfusion 
 
Résumé : 
Contrairement aux systèmes traditionnels de culture cellulaire in vitro, les bioréacteurs à 
perfusion permettent le contrôle rigoureux des paramètres physiologiques de culture qui ont un 
impact sur le comportement et la viabilité des cellules tels que le pH, le flux, la température et 
la concentration en oxygène dissous. Puisque la technologie des bioréacteurs à perfusion est 
relativement nouvelle et que l’intérêt pour ceux-ci est croissant, il devient essentiel de 
développer des méthodes de suivi des fonctions cellulaires dans des conditions dynamiques. 
Dans l’étude présentée ici, des cellules INS-1, une lignée cellulaire capable de secreter 
l'insuline stimulée par glucose, furent enrobees dans la fibrine, cultivées en bioréacteur à 
perfusion pendant 48h et stimulées par la suite avec deux concentrations de glucose pendant 
24h. Des cultures en flacon, ayant subi les mêmes traitements, ont servi de témoin. Les 
cellules exposées a la haute concentration en glucose ont sécrété le plus d’insuline dépendante 
de glycémie, comparativement à celles exposées a la base concentration de glucose. L’indice 
de stimulation, un marqueur de la fonction de la sécrétion d’insuline, a augmenté au cours du 
temps de culture. Une incidence eu cellules apoptotiques (par un essai TUNEL) moins élevée 
fut observée dans les cultures de bioréacteur comparativement aux cultures en flacon. Lors de 
la coloration par  immunofluorescence pour le Ki67 et l’insuline, aucune différence de 
prolifération n’a été observée pour les deux conditions de culture (en bioréacteur et en flacon). 
Toutes les cellules etaient marquées positivement à l’insuline.  
Mots-clés: bioréacteur à perfusion, cellules exprimant l’insuline, culture cellulaire 
tridimensionnelle, essais de sécrétion d'insuline, prolifération cellulaire et apoptose 
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Abstract:  
Perfusion bioreactors, unlike traditional in vitro cell culture systems, offer stringent control of 
physiological parameters such as pH, ﬂow, temperature, and dissolved oxygen concentration, 
which have been shown to have an impact on cellular behaviour and viability. Due to the 
relative infancy and the growing interest in these in vitro culture systems, detection methods to 
monitor cell function under dynamic perfusion bioreactor conditions remains one of the main 
challenges. In this study, INS-1 cells, a cell line which exhibits glucose-stimulated insulin 
secretion, were embedded in ﬁbrin and cultured under perfusion bioreactor conditions for 48 h 
and, then, exposed to either a high-, or low-glucose concentration for 24 h. These cultures 
were compared to non-bioreacted controls. Bioreacted cultures exposed to a high-glucose 
concentration showed the highest glucose-stimulated insulin secretion when compared to those 
in a low-glucose environment. The stimulation index, a marker for insulin secretion 
functionality, increased over time. A lower incidence of apoptotic cells was observed in the 
bioreacted cultures when compared to non-bioreacted ones, as evaluated by a TUNEL assay. 
Immunoﬂuorescence staining of Ki67 and insulin was performed and showed no differences in 
the incidence of proliferative cells between conditions (bioreacted and non-bioreacted), where 
all cells stained positive for insulin. 
Key words: perfusion bioreactors, insulin-expressing cells, 3D cell culture, insulin secretion 
assay, cell proliferation and apoptosis 
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3.1 Introduction 
Culturing insulin-expressing β-cells in matrices not only offers the researcher an in vitro 
model to study diabetes but also offers cells a 3D environment, much alike to their natural in 
vivo microenvironments and so entices cells to behave more natively (Tibbitt and Anseth, 
2009). However, 3D culture systems continue to pose major culture limitations in addition to 
the many technical challenges surrounding their quantification (Babensee et al., 1998; Dubiel 
et al., 2011; Gugerell et al., 2015; Martin and Vermette, 2005b; Walles et al., 2003). 
 
Assessment and quantification of these 3D systems are difficult and variable (Bonnier et al., 
2015). For example, secreted protein concentration is quantified from the medium reservoir 
which lies on top of the 3D matrix construct (Carriel et al., 2012; Sodian et al., 2002b). This 
method might not reveal an accurate picture of the total secreted proteins, as large amounts 
can remain trapped within the matrix (Kuehn et al., 2014a).  Additionally, there may be 
binding domains present in the matrix which may mask the detection of the protein (Cushing 
and Anseth, 2007). Another method to quantify these 3D systems is to enzymatically degrade 
the matrix to reveal protein expression. This method is also flawed as these enzymes also 
affect cells within, causing cell damage and even cell death, thus preventing an accurate 
quantification of the culture (Sabra and Vermette, 2011). 
One promising way to circumvent the problems outlined above is to use a perfusion 
bioreactor. Perfusion bioreactors allow for manipulation of physiological parameters such as 
pH, dissolved oxygen concentration, temperature, and flow, thus, exposing cells to mechanical 
stimuli, faster nutrient and oxygen delivery, and quicker removal of waste materials which 
might impact cell viability and function (Chouinard et al., 2009; Heher et al., 2015). We have 
previously shown that culturing human endothelial cells in fibrin under perfusion bioreactor 
conditions significantly improved cell viability and proliferation, essential milestones for long-
term cell culture (Shkilnyy et al., 2012). Given the relative infancy of using perfusion 
bioreactors, newer and more advanced techniques are required to quantify these systems in 
situ. 
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The aim here was to develop an in situ glucose-stimulated insulin secretion assay on INS-1 
cells, a rat insulinoma beta-like cell line, embedded in fibrin inside a cell culture perfusion 
chamber and dynamically bioreacted for 48h. The cells were then glucose-challenged in situ 
for 24h in either a high-glucose concentration environment or a low-glucose one. Glucose-
stimulated insulin release was then quantified. This study confirmed the hypothesis that 
insulin-expressing cells can survive perfused bioreactor conditions, while maintaining their 
ability to secrete insulin in response to a glucose challenge. 
 
3.2 Materials and Methods 
3.2.1 Reagents, cells and antibodies 
INS-1 cells (C0018007) were purchased from Addexbio Technologies (California, USA). 
Hank’s balanced salts solution (HBSS, H1387), HEPES (H3375), sodium pyruvate (S8636) 
and β-mercaptoethanol (M7522) were obtained from Sigma-Aldrich (ON, Canada). Phosphate 
buffered saline (PBS, BP 665-1) and sodium bicarbonate (MSX03201) were acquired from 
Fisher Scientific (Ottawa, ON, Canada). RPMI-1640 with L-glutamine (31800-022), 
penicillin-streptomycin (15140-122) and trypsin-EDTA (25200-056) were purchased from 
Invitrogen (Burlington, ON, Canada). 
Fibrinogen from bovine plasma (F8630), thrombin from bovine plasma (T9549), 
paraformaldehyde (P6148), aprotinin from bovine lung (A3428), and bovine serum albumin 
(BSA, A7906) were obtained from Sigma-Aldrich. 
Antibody Diluent (S3022) and Fluorescence Mounting Medium (S3023) were acquired from 
Dako (Carpinteria, CA). Normal goat serum (005-000-121) was obtained from Jackson 
ImmunoResearch Laboratories. Rabbit monoclonal antibody to Ki67 (ab16667), and guinea 
pig polyclonal antibody to insulin (ab7542) were both purchased from Abcam (Cambridge, 
MA). DAPI (D1306), Alexa Fluor 555 goat anti-rabbit IgG (A-21428), and Alexa Fluor 488 
goat anti-guinea pig IgG (A-11073) were obtained from Molecular Probes (Eugene, OR). 
CidexPlus® 28 day solution (CX785) and Cidezyme® solution (02-2260) were purchased from 
Cardinal Health Canada (Anjou, QC). Polyethersulfone hollow fibers, each with a lumen 
having a diameter of 1 mm and pore sizes of 0.5 µm in diameter, were obtained from 
Spectrum Laboratories (Racho Dominguez, CA, C75E-021-01N). 
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3.2.2 Bioreactor design, cell culture chamber, and sterilisation 
ADescription of the perfusion bioreactor and of the sterilisation protocol is available 
elsewhere (Appendix A). All detachable bioreactor components including the gas exchange 
system, tubing, and jacketed vessel were cleaned with Cidezyme® to remove any residual 
organic materials and autoclaved. The bioreactor was assembled under a sterile laminar flow 
hood. Further sterilisation was achieved using a basic aldehyde solution (CidexPlus® 28 day 
solution) inserted into the bioreactor and circulated overnight. The bioreactor was rinsed with 
sterile distilled water and the jacketed vessel filled with supplemented RPMI (see below). The 
perfusion chambers containing the fibrin gels were incorporated into the bioreactor. 
The cell culture chamber is described elsewhere (Chouinard et al., 2009). Four 
polyethersulfone hollow fibers, each with a 1-mm lumen and a 0.5-µm diameter pore size, 
were sewn and glued using Hysol® M-1CLTM Medical Epoxy into the central compartment of 
the cell culture chamber. Each chamber piece was autoclaved (121oC for 30 min) and 
assembled. 
 
3.2.3 Cell culture and fibrin gel preparation 
Rat insulinoma cells (INS-1, clone 832/13) (Asfari et al., 1992; Krishnamurthy et al., 2008) 
were cultured in RPMI-1640 with L-glutamine containing 10% foetal bovine serum, 10mM 
HEPES, 1mM sodium pyruvate, 100,000 U L-1 penicillin and 100 mg L-1 streptomycin, and 
50μM β-mercaptoethanol. The medium was changed every 3 days. Cells were incubated at 
37°C ( under 5% CO2) and harvested at 90% confluence with trypsin-EDTA. 
Post-trypsinisation, cells were encapsulated into fibrin. Fibrin gels were prepared from a 2 mg 
mL-1 ﬁbrinogen solution, 0.25 TIU mL-1 aprotinin, 1 U mL-1 of thrombin and 5 million INS-1 
cells per mL. Fibrinogen powder was dissolved in warmed PBS (concentration of 4 mg mL-1) 
and ﬁltered using a 0.22-µm ﬁlter. A 500-µL aliquot of this solution was mixed with 390 µL 
of a 5-million INS-1 cells suspension in PBS. Ten microliters of aprotinin (2.5 U mL-1) were 
added. The solution was homogenised using a pipette. Jelliﬁcation was achieved by adding 
and mixing 100µL of thrombin solution (10 U mL-1 in PBS) to the previous suspension. 
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3.2.4 Dynamic perfusion bioreactor cultures 
Cell-containing fibrin gels were made in the cell culture perfusion chamber. Each chamber had 
a total volume of 1.64 mL, and two chambers were used for each experiment (approximately 
16.5 million cells in total) to ensure that an adequate concentration of insulin could be detected 
by ELISA in the volume of medium of the bioreactor (250 mL). The perfusion chambers were 
hermetically closed and jelliﬁcation was achieved by placing the cell culture chambers in a 
cell culture incubator (5% CO2 and 37
oC) for 20 min. They were then incorporated into the 
bioreactor. These cells were cultured for 48h in circulating supplemented RPMI medium after 
which a glucose-stimulated insulin release assay was performed (detailed below). Culture 
parameters were: temperature (37oC), flowrate (50 mL min-1,), pH (7.4), and dissolved oxygen 
concentration (8.0 mg L-1). 
 
3.2.5 Three-dimensional static culture preparation 
Due to the restricted nature of the size and dimensions of traditional cell culture polystyrene 
plates, the final cell numbers differed between static, 3D cultures and the bioreactor chamber 
cultures. Static, 3D INS-1 cell-containing cultures were prepared in a 12-well tissue culture 
polystyrene plate. The gels were prepared to keep the same thickness (6.53 mm) and the same 
cell concentration (5 million INS-1 cells per mL of fibrinogen solution) as the perfusion 
bioreactor chamber cultures. The same protocol was used to prepare cell-containing fibrin gels 
as outlined above. The total volume of each gel was 2.50 mL equaling approximately 12.5 
million cells per culture. After jellification was achieved (20 min) in a cell culture incubator 
(5% CO2 and 37
oC), medium was added on top. These cells were cultured for 48h in 
supplemented RPMI medium as described above. A traditional glucose-stimulated insulin 
release assay (GSIS) was performed (detailed below). 
 
3.2.6 Two-dimensional static control cultures 
In a parallel experiment, INS-1 cells were plated onto a 6-well TCPS plate at a density of 
0.3x106 cells per well (the number of cells required to achieve ca. 80% confluence after 48h of 
culture). Supplemented RPMI medium (described above) was added on top. These cells were 
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cultured for 48h in a cell culture incubator (5% CO2 and 37
oC). After, a traditional GSIS assay 
was performed and is described below. 
Refer to Figure 1 for a schematic representation of the experimental design. 
 
 
Figure 1 A schematic representation of the experimental design. 
 
3.2.7 Glucose-stimulated insulin secretion (GSIS) 
3.2.7.1 Bioreactor  
INS-1 cells were cultured in the bioreactor for 48h in circulating supplemented RPMI medium 
(11mM glucose), after which, the medium was replaced with Krebs-Ringer buffer with 
HEPES (KRBH) solution supplemented with 2.8mM glucose (referred to as low-glucose) or 
28mM glucose (referred to as high-glucose). Cells were exposed to these circulating media 
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(either high- or low-glucose) for 24h. Samples were taken each hour for the first 7h and the 
final 7h. All media were collected and stored at -20o C for insulin content measurement. After, 
the perfusion chambers were removed from the bioreactor and opened. The cultures were 
washed with warmed PBS and fixed overnight with 4% paraformaldehyde (PFA). Insulin 
content in each of the samples was measured using an insulin (rat) ultra-sensitive enzyme-
linked immunosorbent assay kit (0.002 ng mL-1 sensitivity; 80-INSRTU-E01, Alpco 
Diagnostics, Salem, NH, USA). Absorbance was measured using a Synergy™ HT Multi-
Detection Microplate Reader (Bio-Tek, Winooski, VT, USA). 
 
3.2.7.2 Three-dimensional static cultures  
A traditional GSIS was performed on these cultures. To fully quantify the total insulin release 
in these cultures, both the insulin content from the medium reservoir on top of the culture was 
quantified as was the insulin content within the fibrin gel. Up to 70% of insulin remained 
trapped within the gel and just 30% was found in the medium reservoir on top of the gel (Fig. 
2). In this experiment, 6 cell-containing fibrin gels were needed per experiment. After the 48h 
culture period, the medim was removed and discarded from all 6 gels and 1 gel was lightly 
centrifuged (15 g) to extract the remaining insulin within the gel. The supernatant was 
recovered and stored at -20oC for insulin content measurement. The remaining cell-containing 
gels were subsequently incubated in series, 1h for each incubation step, with KRBH solutions 
with 1. low-glucose (2.8mM); 2. low-glucose (2.8mM) again; 3. high-glucose (28mM); 4. 
high-glucose (28mM) + 50mM 3-isobutyl-1-methyl-xanthine (IBMX; I5879, Sigma-Aldrich); 
and finally 5. low-glucose (2.8mM). After each of the five incubation steps, the media were 
collected and stored at -20oC as well as one gel was sacrificed and lightly centrifuged (15 x g) 
to recover the supernatant, which was stored at -20oC. This entire process was done in 
triplicate (18 INS-1 cell-containing gels were required). Once completed, samples were 
thawed and insulin contents were measured using an insulin (rat) high-range enzyme-linked 
immunosorbent assay kit (0.52 ng mL-1 sensitivity; 80-INSRTH-E01, Alpco Diagnostics). 
Absorbance was measured using a Synergy™ HT Multi-Detection Microplate Reader. 
 
In addition, three additional INS-1 cell-containing fibrin gels were prepared and cultured for 
48h in supplemented RPMI medium (described above) and subjected to the same GSIS 
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protocol but minus the centrifugation step. After the final low-glucose KRBH solution step 
was completed, the gels were washed with warmed PBS and fixed in 4% PFA overnight and 
processed for immunofluorescent staining (see below). 
 
Figure 2 Percentage distribution of insulin secreted by fibrin-embedded INS-1 cells into the 
medium and that remaining within the fibrin gel after 24h of culture in supplemented RPMI. 
Three independent experiments were performed. 
 
3.2.7.3 Two-dimensional static control cultures  
A GSIS test was performed on INS-1 cells cultured on TCPS after 48h of culture in 
supplemented RPMI medium (detailed above). The supplemented RPMI media were 
discarded and replaced with KRBH solutions with 1. low-glucose (2.8mM); 2. low-glucose 
(2.8mM) again; 3. high-glucose (28mM); 4. high-glucose (28mM) + 50mM 3-isobutyl-1-
methyl-xanthine (IBMX; I5879, Sigma-Aldrich); and finally 5. low-glucose (2.8mM), 
consecutively and, each, for 1h. All solutions were collected and stored at -20oC. After, cells 
were detached by trypsin-EDTA treatment, fixed overnight in 4% PFA and processed for 
immunofluorescent staining (see below). 
Samples were thawed and insulin contents were measured using an insulin (rat) high-range 
enzyme-linked immunosorbent assay kit (0.52 ng mL-1 sensitivity; 80-INSRTH-E01, Alpco 
Diagnostics). Absorbance was measured using the same microplate reader. 
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3.2.8 Immunofluorescent staining (Ki67 and insulin) and TUNEL apoptosis 
assay 
Samples were fixed in 4% PFA overnight at 4oC and embedded in warmed 2% agarose 
solution and processed for thin sections in paraffin (Wang and Rosenberg, 1999b). Thin (4-µm 
thick) sections of each sample were deposited on microscope glass slides. Samples were 
deparaffinised, hydrated and blocked in 10% goat serum. Primary antibodies to insulin and 
Ki67 were used. Secondary antibodies were added. All samples were counterstained with 4,6-
diamidino-2-phenylindole, dihydrochloride (DAPI). Manufacturer’s recommendations were 
used for pre-treatment, dilutions, incubation time and temperature. Samples were imaged 
using an epifluorescence microscope (Nikon Eclipse). 
The TUNEL assay was performed as per manufacturer’s guidelines (Kuehn et al., 2014a). 
Paraffin sections of the samples were treated with an APO-BRDU-IHCTM kit (AH1001, 
Phoenix Flow Systems, San Diego, CA, USA) to measure apoptosis by dual colour 
immunohistochemistry. Sections were rehydrated and permeabilised with proteinase K (1:100 
in 10mM Tris pH 8). Endogenous peroxidase inhibition was done with 3% H2O2 in methanol. 
Reaction buffer was added followed by DNA labelling solution. The DNA labelling solution 
contained reaction buffer, TdT enzyme, Br-dUTP and distilled water. Samples were blocked 
with blocking buffer after which an antibody solution containing the anti-BrdU-biotin and 
blocking buffer was added. DAB solution (DAB/H2O2/urea in tap water) was then applied. 
Later, methyl green counterstain solution was applied. Samples were mounted with a 
Permount solution (SP15100, Fisher Scientific) after submerging the samples in 100% ethanol 
and then xylene. Samples were imaged with a Leica DMR HCS microscope system. Pictures 
of at least 10 image sections were taken and manually counted for APO-BrdU-positive cells. 
For each condition, 1200-1400 cells were counted in total.  
 
3.2.9 Data analysis 
Data were obtained from at least five independent samples and statistical analysis was 
presented as means ± standard deviations (SD). The effect of culture conditions was assessed 
by one-way analysis of variance (ANOVA). A p-value < 0.05 was considered statistically 
significant and p-value < 0.001 was considered highly statistically significant. 
 41 
 
3.3 Results and Discussion 
3.3.1 Assessment of INS-1 cells insulin expression by immunofluorescence 
To verify the effect of culture conditions on INS-1 cell insulin expression, cytosolic insulin 
content was assessed in all conditions. All samples were imaged at x100 magnification to 
visualise the unique granular appearance of cytosolic insulin. Only cells with an obvious 
distinguishable nuclear staining were counted. INS-1 cells grown under the tested conditions 
remained insulin-positive (Fig. 3). 
 
 
Figure 3 Immunofluorescence staining for insulin (green). INS-1 cells incubated for 48h in 
fibrin in the perfusion bioreactor and then exposed for 24h to (A) low-glucose (2.8mM) and 
(B) high-glucose (28mM). (C) Static culture of INS-1 cells in fibrin cultured in a cell culture 
incubator and then exposed to a traditional GSIS. (D) Static culture of INS-1 cells cultured on 
TCPS in a cell culture incubator and then exposed to a traditional GSIS. Nuclear staining was 
achieved using DAPI (blue). 100× magnification. Scale bar represents 10µm. 
A Bioreactor, Low-Glucose B          Bioreactor, High-Glucose
D             TCPS + GSIS C Fibrin + GSIS 
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3.3.2 Glucose-stimulated insulin secretion (GSIS) 
To verify INS-1 cell functionality, as a control, INS-1 cells were plated for 48h on tissue 
culture polystyrene (TCPS) first without being embedded in fibrin. A traditional GSIS was 
performed on these cells and the results are presented in Figure 4A. Here, the cells responded 
to stimulation by glucose and IBMX indicating that they were functional. 
 
Tri-dimensional static systems were established by encapsulating INS-1 cells in fibrin and 
culturing them in a CO2 cell culture incubator. This was to investigate the effect of fibrin on 
the cells and to highlight the potential mass transport limitations of static 3D cell culture 
systems. These fibrin gels were of the same thickness as that of the fibrin matrices filling the 
extra-capillary space in the perfusion cell culture chambers connected to the bioreactor. A 
traditional GSIS was performed on these cultures carried out in 12-well tissue culture plates to 
estimate the insulin release from fibrin-embedded INS-1 cells. The results of the GSIS on 
fibrin-embedded INS-1 cells cultured in static are shown in Figure 4B. Cells secreted insulin 
in response to both glucose and IBMX, showing that fibrin can provide a good environment 
for INS-1 cells, as shown by Kuehn et al. and Riopel et al. (Kuehn et al., 2012; Riopel et al., 
2013). 
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Figure 4 Total insulin secreted from INS-1 cells cultured either (A) on TCPS or (B) in fibrin 
in a cell culture incubator for 48h. The cultures were then exposed to low-glucose (LG1) 
(2.8mM), high-glucose (HG) (28mM), HG with IBMX, and finally low-glucose (LG2) 
(2.8mM), consecutively. Individual data points are shown for a triplicate experiment (N = 1, 2, 
3). The stimulation index (S.I.: concentration of insulin from HG divided by that from LG1) is 
calculated for both culture conditions. SD is given as +/- value. 
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in fibrin gels that were made in the cell culture chamber. Two perfusion chambers containing 
fibrin-embedded INS-1 cells were connected to the bioreactor and cultured for 48h. Cultures 
were then exposed to a high-glucose concentration (28 mM) or a low-glucose environment 
(2.8 mM) for 24h. During this time, circulating medium was collected at regular time intervals 
and the subsequent glucose-stimulated insulin release was measured by ELISA. 
In the high-glucose concentration, INS-1 cells secreted more insulin when compared to those 
cultures exposed to the low-glucose environment (Fig. 5A). This indicates that these cultures 
are responsive to glucose under the tested perfusion conditions. The positive linear regression 
observed for both the low-, and high-glucose concentrations in Figure 5A indicates that the 
cultures secrete insulin at a constant rate in response to glucose and that the rate of secretion of 
INS-1 cells was higher when cells were exposed to high-glucose environment (secretion rate 
of 4.4 ng h-1) as opposed to those cultured in low-glucose (secretion rate of 2.4 ng h-1). 
It would have been relevant to normalise insulin release to cell number. However, we have not 
been able to establish a method to determine cell density within fibrin gels. For example, 
dissociating the fibrin with serine proteases, such as plasmin or trypsin, to recover and count 
the cells is problematic. These serine proteases also act upon the cells within the fibrin gels 
causing cell damage and cell death, making cell counting very difficult. We found that 
approximately 60% of the cells did not survive  plasmin-induced fibrin degradation (Sabra and 
Vermette, 2011). Given that cells proliferated under different culture conditions, insulin 
secretion could not be normalized to the initial cell seeding density. 
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from glucose-stimulated insulin release testing obtained under dynamic perfusion conditions 
to those of the 2D static and 3D static systems is not appropriate. 
The stimulation indices (i.e., ratio of insulin concentration measured at a high-glucose 
concentration to that at a low-glucose one for a given time point) were calculated for each 
system and are shown in Figures 4 and 5B. In the case of the bioreactor samples, the 
stimulation index increases over time and appeared to plateau towards the end of the 24-h 
culture period (Fig. 5B). An increase in the stimulation index has been associated with 
improved function of INS-1 cells (Beattie et al., 2002b; Riopel et al., 2013). The graph was 
fitted using an equation for first-order dynamics (y is the stimulation index, A is the asymptotic 
value, t is time, and τp is the process time constant) using Origin 2015 software (OriginLab 
Corp.): 
 
𝑦 = 𝐴(1 − 𝑒
−
𝑡
𝜏𝑝) 
 
A time constant, τp, of 8.7h was found. 
The effect of flow over endocrine pancreatic tissues and cells has not been thoroughly 
addressed, as only a few studies are available. For example, Sankar et al. demonstrated that 
direct flow on mouse islets dampened insulin-secreting β-cell function at the periphery of the 
islet (those cells directly exposed to shear) compared to cells closer to the core. INS-1 cells are 
a carcinoma cell line compared to that of primary mouse tissue and so their behaviour may 
differ accordingly (Sankar et al., 2011). Additionally, Lin et al. used a microfluidic device to 
culture INS-1 cells for 72h exposed to varying glucose concentrations, similar to the glucose 
concentrations used in our experiments. They argue that the change in glucose concentrations 
(11.1 to 25mM) was detrimental and induced more apoptosis compared to those INS-1 cells 
that were consistently exposed to either 11.1mM or 25mM (Lin et al., 2009). 
 
The stimulation indices for the 2D TCPS static cultures and 3D fibrin static cultures are shown 
in Figure 4. A positive effect from the fibrin is evident. The fibrin appears to have a pro-
functional effect on INS-1 cells. This was also confirmed in previous work performed within 
our group (Kuehn et al., 2012). A GSIS test is a functionality assay to compare the insulin 
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secreted from insulin-expressing cells in a low-glucose concentration environment to that of 
insulin secreted from the same cells but exposed to a high-glucose concentration solution. A 
traditional GSIS protocol was used for both the 2D static cultures and the 3D static cultures in 
this study. However, this protocol cannot be translated to every culture system; such is the 
case of a perfusion bioreactor culture in which both a 3D matrix is used and large volumes of 
solution are required to perfuse it. A modified, more relevant GSIS was necessary and 
developed here. 
To put our results in perspective, Graham et al. compared fasting C-peptide levels in different 
mammals. In a healthy human pancreas, it is estimated that there are 1 million islets which are 
composed of 3000 - 4000 cells of which 65-80% of these cells are insulin-producing β-cells. 
Hence, a conservative estimate for the total number of β-cells present in a healthy human 
pancreas would be approx. 1.95 billion. When the human C-peptide concentration is estimated 
for 16.5 million cells (the same number of β-cells used in the bioreactor experiments), a value 
of 0.015 ng mL-1 is obtained (Graham et al., 2011). In contrast,  the perfusion bioreactor 
samples derived from the low-glucose environment (which may closer parallel the fasting 
blood glucose environment used in the C-peptide testing of humans) showed more than six 
times the insulin secretion of that of the human pancreas; the concentration of insulin ranged 
from 0.094 ng mL-1 to 0.371 ng mL-1 after 24h. 
 
One final, important observation should also be noted. It has repeatedly been reported in the 
literature that pancreatic beta cells loose functionality when exposed to a high-glucose 
environment for a prolonged period of time (Bensellam et al., 2009; Dubois et al., 2007; Olson 
et al., 1993). This was not observed in the case of the INS-1 cells cultured in the bioreactor. 
The linear regression seen in Fig. 5A infers that functionality was not impaired, however, it is 
difficult to speculate on the outcome for longer culture periods (> 24 h). 
 
3.3.3 Apoptosis assessment by TUNEL assay 
There was a statistically significant difference when all groups were compared (p < 0.001). A 
higher level of apoptosis was observed in the bioreacted cultures exposed to low-glucose 
conditions when compared to those exposed to the high-glucose environment (p < 0.05) (Fig. 
6A). An explanation for this might be that a low-glucose environment increases metabolic 
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stress in combination with the physical stress induced by shear stress from the flow 
(Bensellam et al., 2009; Flamez et al., 2002; Sankar et al., 2011). 
More than 58% (SEM +/- 8%) of the INS-1 cells were apoptotic in the 3D static culture 
compared to only 41% in the 2D static cultures. At first glance, this finding may be surprising 
as it has previously been shown that fibrin has a positive effect on INS-1 cell cultures, 
exhibiting lower rates of apoptosis than its TCPS controls (Kuehn et al., 2014a; Riopel et al., 
2013). However, the thickness of the fibrin gels used (6.35 mm) in the 3D static experiments 
may offer a possible explanation for this. Great attention was given to the slicing process to 
produce the 4-µm sections used in the TUNEL assay. Slices were taken from different 
positions and thickness of the samples to represent the samples fully. There were areas of the 
fibrin gels where there were mainly apoptotic cells and areas where there were very few 
apoptotic cells (Fig. 6B). The large number of apoptotic cells may be a reflection of the 
transport limitations within the matrix. Those cells at the bottom of the fibrin gel receive fewer 
of the necessary requirements to maintain viability e.g., adequate dissolved O2, removal of 
toxic waste materials, etc. Conversely, the INS-1 cells used in the 2D static TCPS cultures 
undergoing apoptosis may have died, detached and subsequently been washed away during 
medium changes. This is not the case in 3D systems as the cells remain trapped within the 
gels. 
The apoptotic cells seen in the dynamic cultures are much more homogenously distributed 
throughout the culture and do not tend to be located to one particular area of the fibrin gel 
(Fig. 6B). This may highlight the benefits of perfusion bioreactor conditions, as, overall, more 
apoptotic cells were found in static systems when compared to those cultured under perfusion 
conditions. 
Unfortunately, it was not possible to accurately characterise cell state as a function of their 
position within the fibrin gels given the technical limitation of handling a soft matrix which 
lacks rigidity. In addition, the size of the fibrin gels made difficult paraffin embedding as one 
whole piece. Instead, after the culture period was over, the fibrin gels were carefully divided 
into two pieces for processing and paraffin embedding. 
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Figure 6 (A) Percentage of apoptotic INS-1 cells cultured in fibrin under perfusion bioreactor 
conditions for 48h and then exposed to either low-glucose (2.8mM) or high-glucose conditions 
(28mM) for 24h. Additionally, percentage of apoptotic INS-1 cells cultured in fibrin or on 
TCPS in a cell culture incubator for 48h and then exposed to a traditional GSIS. Bars are 
means +/- SD of three independent experiments for each condition. * represents a value of P < 
0.05, *** represents a value of P < 0.001. (B) Light microscopy images of INS-1 cells 
embedded in fibrin and cultured under 3D fibrin static conditions for 48h followed by a 
traditional GSIS. In parallel, INS-1 cells were embedded in fibrin and cultured under perfusion 
bioreactor conditions for 48h and then exposed to KRBH with either low-glucose (2.8mM) or 
high-glucose (28mM) conditions for 24h. In addition, INS-1 cells were cultured on TCPS in 
static conditions for 48h followed by a traditional GSIS. 40× magnification. 
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3.3.4 Assessment of proliferation by immunofluorescence 
Proliferation was assessed using the proliferation marker Ki67. All samples were imaged at 
x100 magnification to assist in the identification of the specific molecular pattern of the Ki67 
proliferation protein associated with the M-phase of the cell cycle (Endl and Gerdes, 2000; 
Vanneste et al., 2009). Examples of this are shown in Figure 7A and Supplementary Figure 1 
(Appendix B). Proliferation rates for bioreacted INS-1 cell cultures exposed to low-glucose or 
high-glucose conditions were on par (38 % (+/- 5.3%) vs. 34% (+/- 6.8%), respectively for 
three independent experiments) (Fig. 7B). The incidence of Ki67-positive cells in the 2D static 
and 3D static cultures was lower (27% (+/- 6.2%) vs. 25% (+/- 4.8%), respectively for three 
independent experiments) (Fig. 7B).  
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Figure 7 (A) Immunofluorescence staining for the Ki67 proliferation protein of INS-1 cells 
embedded in fibrin and cultured under perfusion bioreactor conditions for 48h and then 
exposed to high-glucose (28mM) for 24h. Nuclear staining was achieved using DAPI (blue). 
The arrow points to a cell with the characteristic Ki67 pattern exhibited in M-phase. The mean 
number of Ki67-positive cells was estimated by counting Ki67-positive cells in 40 fields of 
view for each condition. 100× magnification. Scale bar represents 10µm. (B) Assessment of 
INS-1 cell proliferation under perfusion bioreactor conditions after 48h of culture and then 
exposed to either high-glucose (28mM) or low-glucose (2.8mM) for 24h. Additionally, 
assessment of INS-1 cell proliferation of 3D fibrin static and 2D TCPS static cultures. Results 
are expressed as the number of cells expressing the Ki67 proliferation marker relative to the 
number of cells staining for DAPI corresponding to 100% of the total cell population. Bars are 
means +/- SD of three independent experiments for each condition. No statistical significance 
is denoted as ns. 
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However, no statistical significance between groups was observed (p > 0.05). In 3D static 
cultures, there were areas where few or no Ki67-positive cells with fragmented nuclei were 
found, indicating apoptotic cells. Whilst in other areas of the sliced gels, there were much 
more Ki67-positive cells with a lower incidence of fragmented nuclear material. Again, this 
may highlight the transport limitations of the 3D static system. As mentioned, cells which 
lacked viability in the 2D static system were likely to have detached and been washed away 
and therefore not counted. 
 
3.4 Conclusions 
This study reports the successful development of an in situ assay to detect insulin secretion 
over time from insulin-producing cells under perfusion bioreactor conditions. The benefits of 
using such a system are highlighted when compared to conventional tissue culturing 
approaches. This system has the capability of detecting other secreted proteins of interest from 
a host of different tissues. Perfusion bioreactors may allow cells to behave more natively and 
therefore can be used in a number of other applications such as drug delivery and in vitro 
disease pathogenesis modelling. 
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Chapter 4 
 
A FACTORIAL DESIGN TO IDENTIFY PROCESS 
PARAMETERS AFFECTING WHOLE 
MECHANICALLY-DISRUPTED RAT 
PANCREATA IN A PERFUSION BIOREACTOR  
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Titre en francais : Utilisation d'un plan factoriel pour identifiier les paramètres de 
culture en conditions de bioréacteur à perfusion affectant un tissu pancréatique entier obtenu 
par bris mécanique. 
Résumé 
Le flux, la concentration en oxygène dissous (D.O.) et la pulsation ont des effets individuels et 
synergiques sur le tissu pancréatique entier qui ne sont pas décrits dans la littérature. Les 
bioréacteurs à perfusion permettent le contrôle précis sur ces paramètres physiologiques. Dans 
cette étude, un plan factoriel fut employé afin d’évaluer l’effet de ces paramètres sur un 
pancréas de rat obtenu par bris mécanique. Les pancréas de rat furent cultivés en bioréacteur 
pendant 72h sous des conditions définies. L'insuline sécrétée fut mesurée , des colorations 
histologiques par H&E furent effectuées, ainsi que des  marquages par immunofluorescences 
contre l’insuline. Des cultures statiques non réalisées en bioréacteur ont servi de contrôles. Les 
effets combinés du flux et de la D.O. étaient les plus importants à 5h et 24h. La D.O. a eu 
l’effet le plus important sur la qualité des tissus en histologie et la pulsation a eu l’effet le plus 
important sur la quantité de structures positive pour l’insuline observées dans les tissus. Les 
conditions en bioréacteur ayant un flux élevé, une faible D.O., et de la pulsation furent 
choisies pour des investigations plus détaillées. En comparaison avec les témoins, les pancréas 
séparés mécaniquement étant cultivée pour 24h sous ces conditions de culture ont démontré 
une meilleure viabilité, une plus grande sécrétion d’insuline stimulée par glucose, une 
meilleure apparence en histologie, plus de structures positives pour l’insuline et le glucagon et 
plus de structures endothéliales intactes. 
Mots clés : Bioréacteur à perfusion, flux, oxygène dissous, pulsation, pancréas 
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Abstract 
Few studies have reported on whole pancreatic tissue culture, as it is a difficult task using 
traditional culture methods. Here, a factorial design was used to investigate the singular and 
combinational effects of flow, dissolved oxygen concentration (D.O.) and pulsation on whole 
mechanically-disrupted rat pancreata in a perfusion bioreactor. Whole rat pancreata were 
cultured for 72h under defined bioreactor process conditions. Secreted insulin was measured 
and histological (haematoxylin and eosin (H&E)) as well as immunofluorescent insulin 
staining were performed and quantified. The combination of flow and D.O. had the most 
significant effect on secreted insulin at 5h and 24h. The D.O. had the biggest effect on tissue 
histological quality, and pulsation had the biggest effect on the number of insulin-positive 
structures. Based on the factorial design analysis, bioreactor conditions using high flow, low 
D.O. and pulsation were selected to further study glucose-stimulated insulin secretion. Here, 
mechanically-disrupted rat pancreata were cultured for 24h under these bioreactor conditions 
and were then challenged with high glucose concentration for 6h and high glucose + IBMX 
(an insulin secretagogue) for a further 6h. These cultures secreted insulin in response to high 
glucose concentration in the first 6h, however, stimulated-insulin secretion was markedly 
weaker in response to high glucose concentration + IBMX thereafter. Following this 
bioreactor culture period, higher tissue metabolic activity was found compared to that of non-
bioreacted static controls. More insulin- and glucagon-positive structures, and extensive intact 
endothelial structures were observed compared to non-bioreacted static cultures. H&E staining 
revealed more intact tissue compared to static cultures. 
Key Words : Perfusion bioreactor, flow, dissolved oxygen, pulsation, pancreas 
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4.1 Introduction 
Traditionally, one of the main focuses of research on diabetes has been on the islets of 
Langerhans and insulin-producing pancreatic β-cells. Often, in vitro islets are cultured on 
tissue culture polystyrene (TCPS). Islets can be embedded within tridimensional (3D) 
matrices, such as fibrin (Kuehn et al., 2013; Maillard et al., 2011) and alginate (Basta et al., 
2011; Kuehn et al., 2014a), but the observed beneficial effects of these matrices are often 
observed in the short term. Coculturing islets in their natural exocrine matrix may entice islets 
to behave more natively (secrete insulin in response to glucose in a physiological range), an 
approach currently underrepresented in the literature. To date, coculturing the exocrine and 
endocrine pancreas together has proved challenging given the digestive nature of the acini 
component (Logsdon and Williams, 1983). However, more recently Marciniak et al. detailed a 
protocol to coculture the exocrine and endocrine together on thin tissue sections. This 
maintained the native morphology of islets and acinar tissue (Marciniak et al., 2014). 
As in vitro cell culture systems become more sophisticated, an increasing need has arisen to 
understand the effect(s) of changing physiological parameters on pancreatic cell and tissue 
culture outcome. 
The effects of some singular physiological parameters have been investigated. For example, 
using a microfluidic device, Sankar et al. demonstrated that direct flow on isolated mouse 
islets dampened the insulin-secreting function of β-cells at the periphery of the islets i.e., those 
cells directly exposed to shear, compared to cells located deeper within the islets (Sankar et 
al., 2011). Pulsatile flow has also been investigated. Leeser et al. showed that a higher yield of 
viable and functional human islets aimed for transplantation was obtained when the surgically-
removed pancreata, from heart-beating donors, were exposed to pulsatile flow compared to 
those that were not (Leeser et al., 2004). The effect of oxygen on islets has been investigated 
by multiple researchers. Globally, severe hypoxia, akin to the oxygen environment 
transplanted islets initially encounter, has been shown to negatively impact islet yield, 
viability, and functionality (Bloch et al., 2012; Komatsu et al., 2016; Rodriguez-Brotons et al., 
2016). However, moderate hypoxia may have a beneficial effect on islet function (Ma et al., 
2014). Although not confirmed, ‘hypoxia’ in in vitro culture conditions may still be closer to 
the native oxygen tension in vivo.    
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Research into the effect(s) of how these single parameters individually impact pancreatic 
tissue attributes has enriched the diabetes community. However, due to the complexity of the 
pancreatic tissue, it has become more important to understand the combinational effects of 
several parameters on tissue attributes. 
Perfusion bioreactors enable researchers to simultaneously test the effect(s) of multiple, often 
inter-related, physiological parameters e.g., shear stress, pressure, dissolved oxygen 
concentration (D.O.), on cells and tissue both as a function of location and time. We have 
previously reported that culturing primary endothelial cells and rat insulinoma β-cells in fibrin, 
a transient in vivo matrix molecule, under perfusion bioreactor conditions using selected 
parameters, had an overall positive effect when compared to non-bioreacted cultures using just 
fibrin and tissue culture polystyrene (TCPS) (Chouinard et al., 2009; Sharp and Vermette, 
2016; Shkilnyy et al., 2012). Also, the use of a perfusion bioreactor may help minimising the 
potential harmful impact of the digestive enzymes found in the exocrine part of the pancreas 
by washing the enzymes away from the cultured tissue. 
The aim of this present study was to explore the singular and combinational effect(s) of flow, 
pulsation and D.O. on whole rat pancreata using a perfusion bioreactor. We wanted to answer 
the question whether or not whole pancreatic tissue could be cultured while maintaining the 
glucose-stimulated insulin secretion capacity of the tissue and whether perfused bioreactor 
conditions can be beneficial. 
To meet these objectives, a full factorial design was used to investigate these singular and 
combinational effect(s) on the attributes of mechanically-disrupted rat pancreata cultured 
under perfused bioreactor conditions. Due to the multifaceted nature of assessing the effects 
that multiple parameters have on a given culture, a full factorial design should be employed. 
Factorial designs offer the researcher a statistical tool to screen the singular and combination 
effect(s) of several parameters in an efficient manner.  
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4.2 Materials and Methods 
4.2.1 Reagents, cells and antibodies 
Heparin (02303086) was purchased from Sandoz Canada Inc. (Boucherville, QC, Canada). 
Hank’s balanced salts solution (HBSS, H1387), HEPES (H3375), Pefabloc® SC (76307), 
sodium pyruvate (S8636), heparin sodium (H3393), Dulbecco’s modified Eagle’s medium 
(DMEM) (D5523), sodium bicarbonate (S5761), L-glutathione (G4251), 6-hydroxy-2,5,7,8-
tetramethylchromane-2-carboxylic acid (238813), paraformaldehyde (P6148), BS-1 lectin 
(L2895), α-smooth muscle cell actin (C6198), bovine insulin (I6634), and β-mercaptoethanol 
(M7522) were obtained from Sigma-Aldrich (ON, Canada). Phosphate buffered saline (PBS, 
BP 665-1) and MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide) (M5655) 
were acquired from Fisher Scientific (Ottawa, ON, Canada). RPMI-1640 with L-glutamine 
(31800-022), and penicillin-streptomycin (15140-122) were purchased from Invitrogen 
(Burlington, ON, Canada). Organ preservation solution (SPS-1®) was purchased from Organ 
Recovery Systems (Itasca, IL, USA). 
Antibody Diluent (S3022) and Fluorescence Mounting Medium (S3023) were acquired from 
Dako (Carpinteria, CA). Normal goat serum (005-000-121) was obtained from Jackson 
ImmunoResearch Laboratories (Westgrove, PA). Sheep polyclonal antibody to glucagon 
(ab36232), guinea pig polyclonal antibody to insulin (ab7542), and Alexa Fluor 555 rabbit 
anti-sheep were purchased from Abcam (Cambridge, MA). DAPI (D1306), Alexa Fluor 555 
goat anti-rabbit IgG (A-21428), Alexa Fluor 555 goat anti-sheep IgG, and Alexa Fluor 488 
goat anti-guinea pig IgG (A-11073) were obtained from Molecular Probes (Eugene, OR). 
CidexPlus® 28 day solution (CX785) and Cidezyme® solution (02-2260) were purchased from 
Cardinal Health Canada (Anjou, QC). Polyethersulfone hollow fibers, each with a lumen 
having a diameter of 1 mm and a pore size of 0.5 µm in diameter, were obtained from 
Spectrum Laboratories (Racho Dominguez, CA, C75E-021-01N).  
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4.2.2 Bioreactor design, cell culture perfusion chambers and sterilisation 
Descriptions of the perfusion bioreactor and the sterilisation protocols are available elsewhere 
(Sharp and Vermette, 2016; Shkilnyy et al., 2012). All detachable bioreactor components were 
cleaned with Cidezyme® to remove any residual organic materials and autoclaved. Further 
sterilisation was achieved using a basic aldehyde solution (CidexPlus® 28 day solution) 
inserted into the bioreactor and circulated overnight. The bioreactor was rinsed with sterile 
distilled water and the jacketed vessel filled with supplemented pancreatic tissue medium (see 
below). The perfusion chambers containing the mechanically-disrupted rat pancreata were 
incorporated into the bioreactor. 
The perfusion chamber is described elsewhere (Chouinard et al., 2009). Briefly, four 
polyethersulfone hollow fibers, each with a 1-mm lumen and a 0.5-µm diameter pore size, 
were sewn and glued using Hysol® M-1CLTM Medical Epoxy into the central compartment of 
the cell culture chamber. Each chamber piece was autoclaved (121oC for 30 min) and 
assembled. 
 
4.2.3 Whole primary rat pancreatic tissue 
Animals were used in accordance with the local university ethical committee and animal 
guidelines (protocol #367-14). Female Sprague-Dawley rats (Charles River Laboratories Inc.), 
weighing approximately 100 g, were euthanised by CO2 asphyxiation. The rats were then 
surgically opened to reveal the abdominal and thoracic cavities. For each rat, an open incision 
was made to the right cardiac atrium to allow for exsanguination and the effluent flow of 
circulated perfusion fluids. At the same time, the left cardiac ventricle was cannulated using a 
21 G bore needle (BMTM 305167). A heparin solution (10 IU) was then perfused through the 
left ventricle followed by an infusion of organ preservation solution. This was necessary given 
the autodigestive nature of the pancreas. The pancreas was then surgically excised and 
mechanically disrupted using sterile surgical scissors. The disrupted pancreas was then washed 
in supplemented pancreatic tissue medium (see below) three times. 
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4.2.4 Pancreatic tissue medium 
Each disrupted pancreas was suspended in 5 mL of medium comprised of RPMI-1640 (50%) 
and DMEM (50%), 10% foetal bovine serum (FBS), glucose (5.6 mM), L-glutathione (0.62 g 
L-1), Pefabloc® SC (0.2 mM), heparin (100,000 U L-1), sodium bicarbonate (2 g L-1), 100,000 
U L-1 penicillin and 100 mg L-1 streptomycin, and 50 μM β-mercaptoethanol. 
 
4.2.5 Insulin adsorption in the perfusion bioreactor 
Insulin has previously been shown to adsorb on plastic tubing (Thompson et al., 2012). To 
assess the importance of this phenomenon in the bioreactor, bovine insulin (170 ng) was added 
to supplemented rat pancreatic tissue medium and circulated in the perfusion bioreactor for 
72h using high flow, low D.O. and pulsation bioreactor conditions (Table 1). No cells or tissue 
were introduced in the system. Samples of circulating medium were taken throughout and 
analysed using an insulin ELISA (see below). 
 
4.2.6 Enzyme-linked immunosorbent assay (ELISA) to detect insulin 
Insulin contents in each of the collected medium samples were measured using an insulin (rat) 
ultra-sensitive enzyme-linked immunosorbent assay kit (0.002 ng mL-1 sensitivity; 80-
INSRTU-E01, Alpco Diagnostics, Salem, NH, USA). Absorbance was measured using a 
Synergy™ HT Multi-Detection Microplate Reader (Bio-Tek, Winooski, VT, USA). 
 
4.2.7 Factorial design 
The use of a perfusion bioreactor to culture primary tissue is a complex, time consuming and 
costly process involving multiple variables. Thus, a non-replicated full-factorial design was 
used to allow rapid identification of the important process variables affecting pancreatic tissue 
attributes. The bioreactor process conditions as well as the upper and lower thresholds studied 
were as follows: 1) Flow (30 mL min-1 vs. 70 mL min-1); these thresholds were chosen as we 
had previously successfully cultured rat insulinoma cells using the midpoint (50 mL min-1) 
(Sharp and Vermette, 2016). 2) Pulsation (no pulsation vs. pulsation with 130/80 mmHg static 
pressure and 60 bpm frequency); these values were chosen based on previously reported blood 
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pressure and pulse measurements in Sprague-Dawley rats (Parasuraman and Raveendran, 
2012; Wang et al., 2013). 3) D.O. (6 mg L-1 vs. 8 mg L-1); the D.O. in saturated culture media 
at 21% partial pressure and 37°C is 7.02 mg L-1 (Oomen et al., 2016). The selected values 
represent 18% (6 mg L-1) and 24% (8 mg L-1) partial oxygen pressure. Temperature and pH 
were set, respectively, at 37°C and 7.4, for all bioreactor experiments. 
 
Table 1 Upper and lower thresholds of the bioreactor operating conditions used in the factorial 
design experiments. 
Bioreactor Conditions Lower Threshold Upper Threshold 
Flow (mL min
-1
) 30 70 
Pulsation (mmHg, bpm) None 130/80, 60 
D.O. (mg L
-1
) 6 8 
 
 
The chosen thresholds combined with the factorial design of experiments yielded a total of 8 
perfusion bioreactor experiments (Table 2). 
 
 
Table 2 Experimental bioreactor operating conditions studied in the factorial design 
experiments (8 runs in total). 
Run Flow Pulsation D.O. 
1 Low Low Low 
2 High Low Low 
3 Low High Low 
4 High High Low 
5 Low Low High 
6 High Low High 
7 Low High High 
8 High High High 
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4.2.7.1 Factorial design: bioreactor cultures 
One milliliter of mechanically-disrupted rat pancreata (see whole primary rat pancreatic tissue) 
was placed in each perfusion chamber. Two perfusion chambers were used for each 
experiment to ensure that an adequate concentration of insulin could be detected by ELISA in 
the volume of medium used in the bioreactor (300 mL). The perfusion chambers were 
hermetically closed and then incorporated into the bioreactor. Each culture was assigned one 
of the eight bioreactor conditions included in the factorial design (Table 2). The pancreatic 
tissue was then cultured for 72h in circulating supplemented pancreatic tissue medium. 
Circulating medium samples were taken at selected time points throughout. After the tissue 
culture period, both chambers were removed from the bioreactor, opened, and the tissue was 
washed in warmed (37°C) PBS solution and fixed overnight in 4% PFA. 
 
4.2.7.2 Factorial design: non-bioreactor control culture preparation 
In a parallel experiment, 2 mL of mechanically separated pancreatic tissue (see whole primary 
rat pancreatic tissue) were introduced into a tissue culture flask containing 300 mL of 
supplemented pancreatic tissue medium. Medium samples were taken at selected time points 
throughout. The tissue was then cultured in a traditional cell culture incubator (5% CO2, 37
oC) 
for 72h. After the culture, the pancreatic tissue was collected, washed in warmed (37°C) PBS 
solutions and fixed overnight in 4% PFA. 
 
4.2.7.3 Factorial design: preparation of whole pancreatic tissue for histological analysis 
and immunofluorescent staining 
After fixation in 4% PFA overnight, rat pancreatic tissue was washed in a PBS solution and 
embedded in microwave-heated 2% agarose solution and processed for thin sections in 
paraffin. Four-µm thick sections of each sample were deposited on microscope glass slides. 
Samples were then deparaffinised and hydrated. Samples were further processed for 
histological analysis using haematoxylin and eosin (H&E) staining, as well as 
immunofluorescent insulin staining. 
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4.2.7.4 Factorial design: histological analysis 
Samples were stained using freshly prepared haematoxylin and eosin stain. Samples were then 
dehydrated using 100% ethanol and xylene and mounted with a Permount® solution (SP15100, 
Fisher Scientiﬁc). Samples were imaged with a Leica DMR HCS microscope. Multiple slices 
of each sample were stained and imaged to ensure representative coverage of the sample. After 
imaging, samples from each condition were assigned a histology number correlating to tissue 
integrity (Table 3). The use of histological scores (Histo score) allows quantifying these 
results, which is necessary for factorial design analysis.  
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Table 3 Histological scoring criteria used for assessing haematoxylin and eosin (H&E) 
staining. 
Histological Score (Histo score) Description 
1 
<20% supra-nuclear eosin-positive staining 
(overall disproportionately pink appearance); 
<20% defined nuclei; widespread tissue 
fragmentation (>80%). No defined nucleated 
biliary structures (non-nucleated ducts); 
<10% nucleated capillary structures; no 
nucleated islet-like structures observed. 
2 
20-80% supra-nuclear eosin-positive 
staining; 20-80% defined nuclei present; 
tissue fragmentation refined just to the 
borders of the tissue; <60% defined nucleated 
biliary structures present (nucleated ducts 
present); few nucleated capillary structures; 
no nucleated islet-like structures observed. 
3 
>80% supra-nuclear eosin-positive staining 
(strong blue appearance); defined nuclei 
present; <10% tissue fragmentation; defined 
nucleated biliary structures present (>95% of 
all ducts nucleated); defined nucleated 
capillary structures; nucleated islet-like 
structures observed. 
 
 
4.2.7.5 Factorial design: immunofluorescent insulin staining 
Samples were blocked in 10% goat serum. A primary antibody to insulin was used. A 
secondary antibody was then added. All samples were counterstained with 4,6-diamidino-2-
phenylindole, dihydrochloride (DAPI). Manufacturer’s recommendations were used for pre-
treatment, dilutions, incubation time and temperature. Samples were imaged using an 
epifluorescence microscope (Nikon Eclipse). Multiple slices (more than 15) of each sample 
were stained and imaged to ensure representative coverage of the sample. The number of 
insulin- and DAPI-positive structures were quantified and compared between conditions. An 
immunofluorescence score (IF score) was then assigned to each condition (Table 4). The use 
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of immunoflurescence scores allows quantifying these results, which is necessary for factorial 
design analysis. 
The bioreactor conditions which yielded the most beneficial effect(s) on tissue attributes (islet 
structures, extensive ductal system and capillary structures) were selected for further 
investigation. 
 
Table 4 Immunofluorescence score criteria used for assessing insulin-positive structures. 
Immunofluorescence Score (IF score) Number of Insulin-positive Structures 
0 0 
1 ≤ 5 
2 5 < 𝑋 < 10 
3 ≥ 10 
 
 
4.2.8 Selected bioreactor conditions: high flow, low D.O. and pulsation  
Based on the factorial design analysis, bioreactor conditions using high flow, low D.O. and 
pulsation were selected for further investigation and characterisation. Here, experiments were 
performed in triplicate. 
 
Whole rat pancreatic tissue was collected, mechanically-disrupted, and encased into two 
perfusion chambers (1 mL of tissue/chamber). The chambers were connected to the bioreactor 
system for culture, as described above. A sample of this tissue was taken and weighed, and an 
MTT metabolic assay was performed before culture (see below). The pancreatic tissue was 
then cultured for 24h in the bioreactor using circulated pancreatic tissue medium under high 
flow, low D.O. and pulsatile conditions. Medium samples were taken at selected time points 
throughout.  
 67 
 
4.2.8.1 Selected bioreactor conditions: stimulation with glucose and IBMX 
After the 24h culture period, 7 mL of a 0.62 M glucose solution were injected into the 
circulating pancreatic tissue medium (to reach a final concentration of 20 mM glucose in the 
bioreactor volume of 300 mL) for 6h. Samples (1 mL) were taken hourly before an injection 
of 6 mL of a 20 mM glucose solution containing 0.25 M of 3-isobutyl-1-methyl-xanthine 
(IBMX; I5879, Sigma-Aldrich) into the circulating medium to reach a final IBMX 
concentration of 50 μM for a further 6h. Again, samples (1 mL) were taken hourly and an 
insulin ELISA was performed. Insulin measurements were corrected for the volume of the 
medium in the bioreactor i.e., one-milliliter samples were collected each hour from the 
circulating medium, therefore the total volume decreased by 1 mL each hour. After, the 
cultures were removed from the bioreactor, samples of tissue from both perfusion chambers 
were taken and an MTT metabolic assay was performed. The remaining tissue was fixed in 
4% PFA overnight and processed, as described previously. 
 
4.2.8.2 Selected bioreactor conditions: metabolic activity 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide) powder was 
reconstituted in 1x PBS solution (0.5 mg mL-1). Pancreatic tissue was weighed and later 
immersed in this solution and cultured for 1h in a traditional cell culture incubator (37oC, 5% 
CO2). The MTT solution was then aspirated and discarded and the MTT-stained pancreatic 
tissue was submerged in an acidified solvent (0.1 M HCl in 100% ethanol) to solubilise the 
MTT dye overnight. The resulting supernatant was collected and transferred in a 12-well 
tissue culture polystyrene plate for absorbance measurement. The optical density of the 
solubilised dye was measured at a wavelength of 570 nm using a Synergy™ HT Multi-
Detection Microplate Reader (Bio-Tek, Winooski, VT, USA). 
 
4.2.8.3 Selected bioreactor conditions: preparation of pancreatic tissue for histological 
analysis and immunofluorescent staining 
Tissue samples were processed and sliced into thin sections, as previously described. 
Haematoxylin and eosin staining was performed. Immunofluorescent staining was also 
performed (described previously). Primary antibodies to insulin, glucagon, and α-smooth 
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muscle cell actin, were added. Appropriate fluorescently-labelled secondary antibodies were 
then added. All samples were counterstained with DAPI. A fluorescently-labelled BS-1 lectin 
was also used. Manufacturer’s recommendations were used for pre-treatment, dilutions, 
incubation time and temperature. Samples were imaged using an epifluorescence microscope 
(Nikon Eclipse). 
 
4.2.9 Statistical analysis 
The statistical analyses of results obtained from the factorial design experiments and the 
selected bioreactor conditions experiments were performed using Stat-Ease software (Stat-
Ease Inc., Minneapolis, MN). Stat-Ease software uses ANOVA for statistical analysis. A p-
value < 0.05 was considered statistically significant and p-value < 0.001 was considered 
highly statistically significant. 
 
4.3 Results and Discussion 
4.3.1 Screening of bioreactor conditions effects on whole rat pancreata by 
factorial design 
A factorial design was used as a screening tool to identify singular and combinational effect(s) 
of flow rate, dissolved oxygen concentration (D.O.) and pulsation on whole mechanically-
disrupted rat pancreata under perfused bioreactor conditions over 72h. Insulin secretion, H&E 
staining, as well as insulin immunofluorescent staining were assessed for this part of the study. 
Thereafter, based on the factorial design analysis, the bioreactor treatment combination that 
yielded the most statistically significant positive outcome on the pancreatic tissue was selected 
and further investigated. 
Design of experiments and statistical analyses of the results were done using Stat-Ease 
software (Stat-Ease Inc., Minneapolis, MN). Stat-Ease software uses ANOVA for statistical 
analysis. Half-normal plots were used to identify the main singular or combinational effect(s) 
of the bioreactor process conditions on insulin secretion, H&E histological score, and insulin 
immunofluorescence score. 
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4.3.1.1 Factorial design: bioreactor process parameters affecting insulin secretion 
Preliminary tests with the bioreactor revealed that there was a decline in insulin concentration 
over time in the reactor system (Supplementary Fig. 2; Appendix B). We hypothesise that this 
may be caused by insulin adsorption on reactor components and/or degradation/denaturation 
of insulin. With an aim to minimise this phenomenon, supplemented medium was circulated 
24h in advance of each experimental run. Rat pancreata were then mechanically-disrupted and 
cultured in perfusion chambers under defined bioreactor conditions for 72h (Table 1). Samples 
of circulating medium were taken and analysed by insulin ELISA (Fig. 8). A total of 8 
experiments were performed.  
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Half-normal plots presenting the effects and corresponding p-values were used to identify the 
lowest level of significance that would lead to the conclusion that the bioreactor condition 
does not have a statistically significant impact on the selected tissue attribute. As observed 
from the half-normal plot, the statistical analysis of the results showed that the combination of 
flow and D.O. (Flow-D.O.) had the biggest effect on insulin secretion at both 5h and 24h 
(Figs. 9A and 9B, respectively). The interaction between these two parameters caused a 
significant synergistic effect on the resulting insulin secretion profiles (p<0.05). No 
statistically significant, singular or combinational, effect(s) from the other tested parameters 
were observed on the insulin secretion profiles at 48h and 72h time points.  
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Figure 9 Half-normal plots of the effects of flow, D.O. and pulsation bioreactor conditions 
and their interactions on: A) Secreted insulin at 5h; B) Secreted insulin at 24h; C) Histological 
score after 72h of culture; D) Immunofluorescence score after 72h of culture. The p-value of 
the significant effects is shown on each graph, where p<0.05 is considered statistically 
significant. 
 
Each treatment condition yielded a very distinct insulin secretion profile. Visually, pulsation 
appeared to amplify the total amount of insulin secreted when compared to the same treatment 
condition without the use of pulsation. The effect of pulsation on whole pancreatic tissue is 
currently underrepresented in the literature. Aforementioned, to our knowledge, the only study 
to investigate the effects of pulsatile flow on donor whole pancreata revealed that pulsatile 
flow improved viability and functionality of pancreatic islets for transplantation (Leeser et al., 
2004). The exact mechanisms that govern this finding are unknown. However, in vivo 
pancreatic islets are highly vascularised with extensive endothelium exposed to pulsatile flow. 
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For example, the endocrine pancreas accounts for just approximately 2% of the total mass of 
the pancreas but receives ca. 15% of the total blood flow to the pancreas (Jansson et al., 2016). 
In this study, whole pancreata were mechanically-disrupted into small pieces. Although the 
pancreata were disrupted, the endothelium was also present in the tissue pieces. This 
observation may account for this finding. 
A large decrease in the insulin secretion profile was observed in tissue exposed to both high-
flow and low D.O., with and without pulsation. The highest amount of secreted insulin 
appeared at 5h and, thereafter, a large decrease in insulin was observed plateauing after 24h. 
There are a number of possibilities that could explain this: 1. high insulin levels seen at 5h had 
an inhibitory effect on insulin secretion. The remaining circulating insulin was then bound to 
insulin receptors of cells and endocytosed; 2. high insulin levels seen at 5h had an inhibitory 
effect on insulin secretion and the remaining insulin was degraded by the release of proteases 
by necrotic cells/tissue; 3. β-cells lost function after 5h and the remaining circulating insulin 
was degraded by proteases and/or bound to the insulin receptors of cells and endocytosed. 
Control cultures i.e., whole mechanically-disrupted rat pancreata, cultured in a tissue culture 
polystyrene (TCPS) flask incubated in a traditional cell culture incubator, showed an overall 
decrease in the total amount of secreted insulin over time (Fig. 10A).  
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As it is not known how the insulin secretion profile from a healthy functional pancreatic tissue 
should look like in vitro, further characterization techniques are needed to identify process 
conditions yielding acceptable tissue qualities in order to support sufficient insulin secretion. 
 
4.3.1.2 Factorial design: bioreactor conditions affecting the histology of whole disrupted 
pancreatic tissue 
After each bioreactor experiment, pancreatic tissue pieces were fixed, processed, and stained 
with H&E. This stain was used to assess the overall state of the tissue after exposure to the 
chosen bioreactor process conditions (Fig. 11). The pancreatic tissue from each condition was 
then assigned a histological score according to the criteria outlined in Table 3. The histological 
scores are shown at the bottom right of each image in Figure 11(more images can be found in 
Appendix C). Again, distinct differences were observed between conditions. Whole rat 
pancreas exposed to high flow, low D.O. and pulsation yielded the highest histological score. 
Rat pancreas exposed to low flow, low D.O. and pulsation yielded the second highest 
histological score. This may suggest that pulsation in combination with low D.O. had a 
beneficial effect on tissue outcome.  
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Figure 11 Representative haematoxylin and eosin (H&E) staining of whole mechanically-
disrupted rat pancreata cultured in supplemented medium (5.6 mM glucose) after 72h of 
culture under the respective bioreactor process conditions. The histological score (Histo Score) 
is indicated at the bottom right of each image (represents the average score of all imaged 
sections). Scale bar represents 100 µm. Arrows are numbered and show important tissue 
features: 1. Fragmented tissue, 2. Denucleated tissue, 3. Pancreatic islet, 4. Nucleated ducts 
with strong blue tissue appearance. 
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Control cultures i.e., whole mechanically-disrupted rat pancreata cultured in a TCPS flask 
maintained in a traditional cell culture incubator, were assigned the lowest histological score 
(indicated at the bottom right of the image in Fig. 10B). 
The half-normal plot revealed that D.O. had the most statistically significant effect (p<0.05) 
on tissue histological outcomes (Table 3) after 72h of culture (Fig. 9C). Low D.O. (6 mg L-1) 
was the most advantageous condition overall. 
4.3.1.3 Factorial design: bioreactor conditions affecting insulin-positive cells 
After each bioreactor experiment, pancreatic tissue pieces were fixed, processed, and 
immunofluorescently stained for insulin (Fig. 12). More than 15 slices of whole rat pancreatic 
tissues were stained to represent the full specimen. Each treatment condition was assigned an 
immunofluorescence number (Table 4), which corresponded to the overall number of insulin-
positive structures observed in the total number of images taken.  
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Figure 12 Representative immunofluorescent insulin staining (green) and DAPI staining 
(blue) on mechanically-disrupted rat pancreata cultured in supplemented medium (5.6 mM 
glucose) after 72h under the respective bioreactor process conditions. The immunofluoresce 
score (IF Score) is indicated at the bottom right of each image. Scale bar represents 100 µm. 
  
Pulsation No Pulsation 
H
ig
h
 f
lo
w
, H
ig
h
 D
.O
. 
Lo
w
 f
lo
w
, H
ig
h
 D
.O
. 
H
ig
h
 f
lo
w
, L
o
w
 D
.O
. 
Lo
w
 f
lo
w
, L
o
w
 D
.O
. 
IF Score: 1
IF Score: 0IF Score: 3
IF Score: 1 IF Score:  0
IF Score: 0
IF Score: 2 IF Score: 0
 79 
 
Insulin-positive structures were found in all pulsated conditions (Fig. 12). However, the 
intensity of the insulin and DAPI staining in rat pancreas exposed to high flow, high D.O. and 
pulsation was markedly weaker, and fewer insulin-positive structures were found overall. 
Fewer insulin-positive structures were also found in rat pancreatic tissue exposed to low flow, 
high D.O. and pulsation. However, signal intensity did not appear to be diminished under 
these conditions. 
No insulin-positive structures were found in conditions without pulsation. 
Control cultures i.e., whole mechanically-disrupted rat pancreata cultured in a TCPS flask 
maintained in a traditional cell culture incubator, showed no insulin-positive structures and 
thus were assigned the lowest immunofluorescence score (Fig. 10C). 
The half-normal plot revealed that pulsation had the most statistically significant effect 
(p<0.05) on the number of insulin-positive structures observed in the mechanically-disrupted 
tissue after 72h of culture (Fig. 9D). Conditions that included pulsation had the most 
advantageous effect on the presence and number of insulin-positive structures. 
In light of the factorial design findings, whole rat pancreata were mechanically-disrupted and 
cultured in perfusion chambers under bioreactor conditions in triplicate using the following 
bioreactor conditions: high flow (70 ml min-1), low D.O. (6 mg mL-1) and pulsation (130/80 
mmHg, 60bpm) for 24h.  
 
4.3.2 Investigation of selected bioreactor conditions: high flow, low D.O. and 
pulsation 
4.3.2.1 Insulin secretion and stimulation with glucose and IBMX 
Whole rat pancreata were mechanically-disrupted and cultured 24h in perfusion chambers 
under high flow, low D.O. and pulsation conditions in the bioreactor. Functionality of the 
tissue was then assessed by spiking of the medium with glucose for 6h and later spiking with 
IBMX for a further 6h. Samples of circulating medium were taken and analysed by insulin 
ELISA (Fig. 13). Experiments were performed in triplicate. 
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bioreactor experiments under the same bioreactor conditions (high flow, low D.O. and 
pulsation) (Fig. 8). Again, the secreted insulin peaked at 5h and plateaued by 24h. The 
variations in the total amounts of secreted insulin are likely due to differences in size of 
pancreata between rats. Some yielded more tissue than others, thus more endocrine tissue may 
have been present. Although disrupted pancreata were suspended in the same volume of 
medium (each disrupted pancreas was suspended in 5 mL of pancreatic tissue medium), each 
volume of the tissue suspension might contain different amounts of tissue. Non-bioreacted 
control cultures showed a net decrease of secreted insulin (Fig. 14A.) over 24h in all three 
experiments similar to that seen in the factorial design (Fig. 10A). 
Upon stimulation with high glucose concentration, all bioreactor cultures showed an 
immediate increase in insulin secretion in the first hour (Figs. 13B, 13D, 13F) and an overall 
increase after 6h of high glucose stimulation. Upon stimulation with high glucose 
concentration + IBMX, a decrease was observed in the first hour of all three experiments but 
an overall increase was observed over the 6h culture period. However, little stimulatory effect 
from high glucose concentration + IBMX was observed when compared to stimulation with 
just high glucose concentration (Fig. 14C). Possible scenarios that may explain this 
observation include: 1) IBMX-induced insulin secretion could be inhibited and examples of 
this can be found elsewhere in the literature  (Christie and Ashcroft, 1984; Draznin et al., 
1985; Poitout et al., 1998). Given that bioreactor conditions and full pancreatic tissue were 
used, this could result into the inhibition of the effects of IBMX, as this was never tested. Most 
studies reporting the stimulatory effect of IBMX on insulin secretion involved just (rat) islets 
(Cunningham et al., 2003; de Groot et al., 2004; Yamada et al., 2002), 2) pancreatic islets lost 
their sensitivity to secrete insulin to high glucose concentrations over the 12h stimulatory time 
and IBMX is solely responsible for the stimulation observed in the final 6h of stimulation 
(non-glucose-stimulated insulin secretion) (Cunningham et al., 2003; Grill and Bjorklund, 
2001; de Groot et al., 2004; Poitout and Robertson, 2002; Yamada et al., 2002). 3) Beta cells 
died during this culture period (Borg et al., 2016; Kayton et al., 2015).   
In a traditional glucose-stimulated insulin secretion assay, a low glucose concentration (2.8 
mM) step would normally follow the high glucose concentration and high glucose 
concentration + IBMX steps described here. However, this was not envisioned here as this 
 82 
 
ZRXOGKDYHLQYROYHGUHSODFLQJWKHFLUFXODWLQJVXSSOHPHQWHGUDWSDQFUHDWLFPHGLXPZLWKIUHVK
PHGLXP:H IHOW LWZRXOGEHKDUG WR FRPSDUH WKH LQVXOLQ VHFUHWLRQV JLYHQ WKDW WKHPHGLXP
FRPSRVLWLRQ DIWHU HVVHQWLDOO\ K RI FXOWXUH ZRXOG PRVW OLNHO\ KDYH D GLIIHUHQW RYHUDOO
FRPSRVLWLRQPHWDEROLWHVFHOOXODUZDVWHHWF,QDGGLWLRQLQVXOLQVHFUHWLRQXQGHUORZJOXFRVH
FRQFHQWUDWLRQ PD\ IDOO EHORZ WKH LQVXOLQ FRQFHQWUDWLRQ UDQJH WR EH GHWHFWHG E\ DQ XOWUD
VHQVLWLYH LQVXOLQ (/,6$ SOHDVH QRWH WKDW  P/ RI PHGLXP ZHUH XVHG SHU ELRUHDFWRU
H[SHULPHQW
 
)LJXUH  $ ,QVXOLQ VHFUHWLRQ SHU YROXPH P/ RI ZKROH PHFKDQLFDOO\GLVUXSWHG UDW
SDQFUHDWDFXOWXUHGLQVXSSOHPHQWHGPHGLXPP0JOXFRVHLQ7&36IODVNVPDLQWDLQHGLQD
WUDGLWLRQDOFHOOFXOWXUHLQFXEDWRURYHUKDQG%WKHVXEVHTXHQWUHVSHFWLYHLQVXOLQVHFUHWLRQLQ
UHVSRQVHWRKLJKJOXFRVHFRQFHQWUDWLRQP0IRUKIROORZHGE\DQRWKHUKLQKLJKJOXFRVH
FRQFHQWUDWLRQ P0 ,%0;ȝ07KH WKUHHSURILOHV VTXDUH WULDQJOHDQGGLDPRQG
VKDSHV UHIHU WR  LQGHSHQGHQW H[SHULPHQWV& 'HOWD RI LQVXOLQ FRQFHQWUDWLRQ IURP ZKROH
PHFKDQLFDOO\GLVUXSWHG UDW SDQFUHDWD FXOWXUHG XQGHU ELRUHDFWRU FRQGLWLRQV XSRQ VWLPXODWLRQ
ZLWK KLJK JOXFRVH FRQFHQWUDWLRQ  P0 EHWZHHQ K WRWDO DPRXQW RI LQVXOLQ DW K
VXEWUDFWHG IURP WRWDO DPRXQWRI LQVXOLQ DW K DQGKLJK JOXFRVH FRQFHQWUDWLRQ P0
,%0;ȝ0EHWZHHQKWRWDODPRXQWRILQVXOLQDWKVXEWUDFWHGIURPWRWDODPRXQW
RI LQVXOLQDWK'0HWDEROLF077DVVHVVPHQWRISDQFUHDWLF WLVVXHDW WLPHDVZHOODV
DIWHUFXOWXUHDQGVWLPXODWLRQVWXGLHVZDVSHUIRUPHGRQELRUHDFWHGDQGQRQELRUHDFWHGFXOWXUHV
DVPHDVXUHGE\RSWLFDOGHQVLW\UHSUHVHQWVDYDOXHRIS
A) B)
0
100
200
300
400
500
600
0 2 4 6 8 10 12 14 16 18 20 22 24
Se
cr
et
ed
 In
su
lin
 (n
g 
m
L-1
tis
su
e)
Time (h)
300
320
340
360
380
400
420
440
460
480
24 25 26 27 28 29 30 31 32 33 34 35 36
Se
cr
et
ed
 In
su
lin
 (n
g 
m
L-1
 ti
ss
ue
)
Time (h)C) D)
0
20
40
60
80
100
120
140
160
N=1 N=2 N=3
De
lta
 In
su
lin
 C
on
ce
nt
ra
tio
n 
   
   
   
   
  
(n
g 
m
L-1
tis
su
e)
 
Bioreactor Experiments 
High Glucose
High Glucose + IBMX
0
0.5
1
1.5
2
2.5
time 0 Bioreactor Cultures Static Cultures
O
pt
ica
l D
en
sit
y 
(5
70
nm
) g
-1
tis
su
e
Conditions 
***
 83 
 
No stimulatory effect by glucose or IBMX was observed in non-bioreacted control cultures 
(i.e., in TCPS flasks) and a minor decrease in insulin was observed over this time period (Fig. 
14B). 
 
4.3.2.2 Selected bioreactor conditions: metabolic activity 
An assay for metabolic activity based on MTT was performed on rat pancreata before culture 
(time 0) and after 24h of culture followed by glucose stimulation (for 6h) and glucose 
stimulation + IBMX (for 6h). Bioreacted cultures of whole mechanically-disrupted rat 
pancreata showed a statistically significant (p<0.001) higher metabolic activity than their 
respective control cultures (Fig. 14D) suggesting that the bioreactor conditions used (high 
flow, low D.O. and pulsation) had a positive effect on tissue metabolic activity and, therefore, 
on their viability. 
 
4.3.2.3 Selected bioreactor conditions: histology and immunofluorescent staining of 
insulin, glucagon and α-smooth muscle cell actin (α-SMCA) 
H&E staining was performed and evaluated on bioreacted and non-bioreacted control cultures 
after each experiment (Figs. 15A and 15B). A histological score was then assigned (Table 3). 
Rat pancreas exposed to high flow, low D.O. and pulsation yielded the highest histological 
score (3) whilst non-bioreacted control cultures were assigned the lowest score. 
Bioreacted cultures stained positive for insulin and glucagon throughout the tissue and were 
assigned the highest immunofluorescence score for insulin-positive structures (Fig. 15C). No 
insulin- or glucagon-positive structures were observed in control experiments and, thus, they 
were assigned the lowest immunofluorescence score for insulin-positive structures (Fig. 15D).  
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Figure 15 Representative staining of whole mechanically-disrupted rat pancreata cultured in 
supplemented medium (5.6 mM glucose) after 24h of culture and stimulation with high 
glucose, as well as high glucose + IBMX under bioreactor conditions (high flow, low D.O. 
and pulsation) for A) Haematoxylin and eosin (H&E). C) Insulin and glucagon 
(counterstained with DAPI). E) α-SMCA and BS-lectin (counterstained with DAPI). Non-
bioreacted static control cultures in TCPS flasks stained with B) haematoxylin and eosin 
(H&E). D) Insulin and glucagon (counterstained with DAPI). F) α-SMCA and BS-lectin 
(counterstained with DAPI). The respective histological (Histo Score) and 
immunofluorescence (IF Score) scores are located at the bottom right of each image and 
represent the average score of all images analysed. Scale bar represents 100 µm. Arrows are 
Histo Score:  3 Histo Score: 1
IF Score: 0IF Score: 3
A
C
B
D
FE
1
2
3
4
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numbered and show important tissue features: 1. Pancreatic islet, 2. Nucleated capillary, 3. 
Fragmented tissue, 4. Denucleated tissue. 
 
The presence of intact vessel walls in the pancreatic tissue after culture was also investigated 
using α-SMCA. In addition, endothelial cells were stained using a fluorescently-labelled BS-
lectin to stain both the ductal endothelial cells and the endothelial cells of the vasculature. 
Bioreacted cultures showed strong staining for both throughout the tissue. Interestingly, non-
bioreacted control cultures stained positive for α-SMCA but few lectin-positive structures 
were observed. In addition, the nuclear staining (DAPI) was markedly weaker than in areas  of 
bioreacted cultures, which may indicate wide-spread destruction of the tissue (Johnson and 
Rabinovitch, 2012). Unfortunately, we were not able to quantify this part of the study given 
the complicated nature of the pancreatic vasculature and ductal system. 
This part of the study aimed to further explore the effects of high flow, low D.O. and pulsation 
on whole mechanically-disrupted rat pancreata. To our knowledge, this is the first study of its 
kind, thus, it is difficult to speculate on the exact mechanisms that are responsible for the 
beneficial effects observed when compared to non-bioreacted static cultures. Perhaps the 
improved mass transport provided by perfusion bioreactors may explain part of the observed 
beneficial effects (Martin and Vermette, 2005a). Also, pulsation is known to influence cell 
behaviour (Balcells et al., 2005; Chin et al., 2011; Helmlinger et al., 1991) and further 
improves mass transport (Thuenauer et al., 2014). For example, as previously mentioned, 
Leeser et al. showed that a higher yield of viable and functional human islets aimed for 
transplantation was obtained when the surgically-removed pancreata, from heart-beating 
donors, were exposed to pulsatile flow compared to those that were not (Leeser et al., 2004). 
We were able to demonstrate that bioreacted cultures remained viable (i.e., metabolically 
active), showed glucose-stimulated insulin secretion and had vascular and ductal structures. 
The overall tissue appeared intact over the culture period. 
4.4 Conclusion 
This study reports on the single and combinational effects of flow, dissolved oxygen 
concentration (D.O.) and pulsation on whole mechanically-disrupted rat pancreata using a 
perfusion bioreactor. Favourable, but yet to be optimised, bioreactor conditions to culture 
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pancreatic tissues were found in these experiments (high flow, low D.O. and pulsation). 
Essentially, this study raises many important questions about insulin-release kinetics, the 
interaction between the endocrine and exocrine pancreas, and how the pancreas responds 
under defined conditions in vitro. The fact that glucose-stimulated insulin secretion and 
histological attributes from whole pancreatic tissue were at least partly preserved opens the 
door to further develop a bioprocess to produce viable and functional whole pancreatic tissue, 
with endocrine functions, without the requirements for isolation and purification. It is clear 
that further study is needed to understand the mechanisms that govern the observations 
presented in this manuscript. In doing so, this information could be used to improve allogenic 
pancreatic endocrine grafts which offer a potential cure for type 1 diabetes mellitus. 
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Conclusions – Français 
 
Les travaux de cette thèse avaient pour but d’élaborer et de valide les paramètres d’opération 
d’un bioréacteur à perfusion permettant la culture d’un tissu pancréatique entiers. 
Les travaux décrits au chapitre 3 « An in-situ glucose-stimulated insulin secretion assay under 
perfusion bioreactor conditions » ont permis de contourner certaines limitations liées à la 
quantification de systèmes de culture cellulaire en 3D. De plus, ces travaux soulignent les 
effets bénéfiques de l’utilisation des bioréacteurs à perfusion pour entretenir des cultures 
cellulaires. Dans l’étude présentée ici, un bioréacteur à perfusion a été employé pour la culture 
de cellules INS-1 enrobees dans fibrine, et ce, dans des conditions physiologiques contrôlées. 
Ces cultures ont sécrété de l’insuline gluco-dépendante en fonction du temps. De plus, l’indice 
de stimulation a démontré que la fonctionnalité de ces cultures augmentait au cours de la 
culture. Une incidence plus basse de cellules apoptotiques a été observée dans ces cultures 
comparativement à celles n’ayant pas été cultivées en bioréacteur, c’est-à-dire des cultures en 
3D statiques  (Sharp and Vermette, 2017). 
Ces premiers résultats sont prometteurs; cependant, une grande précaution doit être de mise 
avant d’étendre ces mêmes conclusions aux lignées cellulaires non malignes ou aux cultures 
de tissus primaires.  
Les cellules INS-1 restent une lignée irradiée d’insulinome provenant de rat. Bien qu’elles 
réagissent à des concentrations physiologiques en glucose, elles sont prolifératives et n’ont 
que 20% du contenu total en insuline des cellules β natives de pancréas (Asfari et al., 1992; 
Riopel et al., 2013), ce qui rend ces deux types de cellules difficiles à comparer. Enfin, 
l’immortalité des lignées cellulaires peut causer des altérations de morphologie, de 
l’expression protéique ainsi que du profil épigénétique (Kwakkenbos et al., 2016; Maqsood et 
al., 2013). 
Cependant, l’utilisation des cellules INS-1 dans le milieu de la recherche n’est pas à rejeter. 
Au contraire, cette lignée de cellules peut servir comme modèle pour la mise au point 
d’approches d’imagerie en temps réel de cultures en 3D ainsi que pour des analyses 
quantitatives de cultures de cellules diabétiques en 3D. Par exemple, la co-culture de cellules 
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INS-1 et endothéliales en matrice 3D, dans les conditions contrôlées d’un bioréacteur à 
perfusion, pourrait servir de modèle de revascularisation d’îlots pancréatiques. 
De manière générale, cette étude s’est concentrée sur les applications du bioréacteur à 
perfusion à des fins de recherche sur le diabète alors qu’il est possible d’utiliser cet outil pour 
une gamme variée d’expérimentations. Par exemple, il serait possible de mesurer des protéines 
sécrétées d’intérêt, provenant d’autres types de cellules ou de tissus, en temps réel avec la 
même méthodologie que celle décrite dans cette thèse.  
La deuxième étude expérimentale décrite au chapitre 4 « A factorial design to identify process 
parameters affecting whole mechanically-disrupted rat pancreata in a perfusion bioreactor » a 
été fondée sur les résultats du chapitre 3. Dans les travaux subséquents, des pancréas de rats 
dissociés mécaniquement ont été exposés, dans un bioréacteur à perfusion, à des combinaisons 
différentes de flux, D.O. et pulsation. Un modèle expérimental multifactoriel sans réplica a été 
utilisé comme outil de criblage afin d’évaluer les effets individuelles et combinés des 
conditions du bioréacteur sur le tissu. Les paramètres menant aux effets les plus intéressants 
sur le tissu pancréatique ont été choisis et caractérisés plus amplement. 
Les pancréas de rat dissociés mécaniquement exposés à un flux élevé (70 mL min-1), une 
faible D.O. (6 mg L-1) et une pulsation (130/80 mmHG, 60 bpm) dans un bioréacteur à 
perfusion ont démontré une sécrétion d’insuline en réponse au glucose, de la coloration 
d’immunofluorescence à l’insuline et au glucagon, des canalisations et des vascularisations. 
Les tissus semblaient donc être en bonne condition d’un point de vue histologique après 
culture. Toutefois, plusieurs questions sont restées sans réponse. Par exemple, il faut souligner 
que, sans réplicats de tous les paramètres testés en bioréacteur (tableau 2), il n’est pas possible 
de tirer une conclusion générale de l’effet de chaque paramètre sur le tissu pancréatique. Les 
résultats des paramètres testés dans le cadre du modèle expérimental multifactoriel doivent 
donc demeurer des observations pour l’instant. 
Les prochains travaux devraient inclure l’investigation des cinétiques de sécrétion d’insuline 
par des pancréas dissociés mécaniquement pour chaque condition du bioréacteur, en plus 
d’étudier comment ces paramètres modifient la culture du tissu pancréatique eu fonction du 
temps. Aussi, il serait intéressant de porter une attention particulière sur les effets des 
paramètres sur le tissu exocrine. Nous avons examiné par histologie l’apparence générale du 
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tissu pancréatique avec une coloration de type H&E.  Nous avons aussi examiné le 
fonctionnement des cellules β pancréatiques par le biais de la sécrétion d’insuline gluco-
dépendante et de la coloration par immunofluorescence. Cependant, les fonctions du tissu 
exocrine n’ont pas été étudiées. Ce dernier mérite une attention particulière pour des études 
subséquentes car, à ce jour, peu est connu quant à la co-culture de tissus endocrine et exocrine 
de pancréas et les effets des paramètres physiologiques contrôlés de cette co-culture in vitro le 
sont encore moins. 
Afin de mettre cette étude en perspective, ces connaissances pourraient améliorer notre 
compréhension des facteurs qui déterminent les greffes réussies d’îlots pancréatiques. Jusqu’à 
maintenant, les îlots pancréatiques sont dissociés mécaniquement et/ou de manière 
enzymatique du pancréas entier avant qu’ils ne soient greffés chez des patients atteints de 
T1DM (Shapiro et al, 2000). La perte de l’environnement natif et des molécules provenant de 
la ECM a été démontrée comme étant un facteur limitant le succès des greffes (Llacua et al., 
2016; Nagata et al., 2001 ; Tatum et al., 2017). Une manière d’améliorer le taux de succès de 
ces greffes pourrait être la mise au point des conditions optimales d’une pré-culture en 
bioréacteur où l’on ajouterait un hydrogel contenant des molécules de la ECM. D’ailleurs, la 
co-culture d’îlots pancréatiques et de cellules endothéliales du receveur, effectuée avant la 
greffe et sous conditions de bioréacteur à perfusion, pourrait aider à la revascularisation de la 
greffe et à contourner la réaction immunitaire chez l’hôte. Toutefois, des études plus poussées 
sur les conditions de culture en bioréacteur seront nécessaires avant que ce ne soit possible. 
En résumé, cette thèse démontre que les bioréacteurs à perfusion permettent le contrôle 
rigoureux de paramètres physiologiques, offrant aux cellules et aux tissus un environnement 
ressemblant à leur milieu natif et ainsi aider les cellules à adopter un comportement plus 
naturel (Sécréter de l'insuline en réponse au glucose d'une manière physiologique). Plusieurs 
conditions de bioréacteur ont été examinées, permettant aux conditions de cultures les plus 
avantageuses pour les cellules pancréatiques de rat d’être identifiées. Ces connaissances 
devraient servir à l’amélioration du taux de succès des greffes d’îlots allogènes. 
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Conclusion – English 
The experimental work of this thesis aimed to develop and validate perfusion bioreactor 
process conditions for the culture of pancreatic tissue.  
The experimental work described in Chapter 3 entitled, “An in-situ glucose-stimulated insulin 
secretion assay under perfusion bioreactor conditions” attempted to circumvent some of the 
limitations associated with quantification of 3D cell culture systems in addition to highlighting 
the beneficial effects of using perfusion bioreactors to culture cells. Here, a perfusion 
bioreactor was used to culture INS-1 cells embedded in fibrin matrices under defined 
physiological conditions. These cultures showed glucose-stimulated insulin secretion over 
time. In addition, they showed improving functionality over time (assessed by the stimulation 
index). A lower incidence of apoptotic cells was also observed in these cultures when 
compared to non-bioreacted 3D static control cultures (Sharp and Vermette, 2016).  
Although these results were encouraging extreme caution should be exercised when 
attempting to generalise these results to non-malignant cell lines or primary tissue. INS-1 cells 
are an irradiated rat insulinoma cell line. Although they have been shown to respond to 
physiological ranges of glucose, they are proliferative, and the total insulin content is just 20% 
of that of the native pancreatic β-cell (Asfari et al., 1992; Riopel et al., 2013). This makes it 
difficult to establish comparisons to native pancreatic β-cells. In addition, immortalisation of 
cell lines may cause alterations in cell morphology, protein expression, and epigenetic profile 
(Kwakkenbos et al., 2016; Maqsood et al., 2013).  
However, the use of INS-1 cells in research should not be dismissed as these cells may still act 
as a good model for further work on optimising real-time imaging of 3D cultures and other 
quantitative analysis of 3D diabetes cell culture models. For example, co-culturing INS-1 cells 
with endothelial cells in a 3D matrix under defined perfusion bioreactor conditions could be 
used as a model for revascularisation of pancreatic islets. 
Globally, this study focused on the application of a perfusion bioreactor for the purposes of 
diabetes research, however, its uses are more widespread. For example, other secreted proteins 
of interest from different cells or tissue could be measured in real-time in a similar fashion 
using the method detailed in this part of the thesis.  
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Based on results of the first experimental work described in Chapter 3, the second 
experimental study (Chapter 4) was designed and entitled “A factorial design to identify 
process parameters affecting whole mechanically-disrupted rat pancreata in a perfusion 
bioreactor”. Here, mechanically-disrupted rat pancreata were exposed to different 
combinations of flow, D.O., and pulsation using a perfusion bioreactor. A non-replicated 
factorial design was used as a screening tool to assess the singular and combination effects of 
these bioreactor conditions on the outcome of the tissue. The bioreactor conditions that yielded 
the most beneficial effects on the rat pancreatic tissue were then selected, and further 
characterisation on replicate experiments were performed.  
Mechanically-disrupted rat pancreata exposed to high flow (70 mL min-1), low D.O. (6 mg L-
1), and pulsation (130/80 mmHg, 60 bpm) using a perfusion bioreactor showed glucose-
stimulated insulin secretion, immunofluorescent staining for insulin and glucagon, and 
vascular and ductal structures, and appeared to be in good histological condition after culture. 
However, a plethora of questions remain unanswered. For example, the use of a non-replicated 
factorial design as a screening tool was sufficient for the objectives of this study. However, it 
should be noted that without replication of all bioreactor conditions used (Table 2) it is 
difficult to make broad conclusions about the absolute effects each bioreactor condition had on 
the pancreatic tissue. Therefore the results for the non-replicated factorial design conditions 
remain observations at this time.  
Further work should include the investigation of the kinetics of insulin release by 
mechanically-disrupted rat pancreata for each of the bioreactor conditions and how they relate 
to pancreatic tissue outcome. In addition, the impact of these bioreactor conditions on the 
exocrine tissue should receive special attention. Globally, we assessed the overall histological 
state of the pancreatic tissue using H&E staining. We also assessed pancreatic β-cell function 
through glucose-stimulated insulin release and immunofluorescent staining. However, we did 
not assess functionality of the exocrine tissue. This should be a strong consideration for further 
study as, to date, little is known about the co-culture of endocrine and exocrine pancreas and 
even less is known about the effects of defined physiological parameters on this co-culture in 
vitro.  
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To put this study into perspective, this knowledge could be used to improve our understanding 
of factors that influence a successful pancreatic islet graft. Currently, pancreatic islets are 
mechanically- and/or enzymatically-isolated from the whole pancreas prior to their 
transplantation into patients with T1DM (Shapiro et al., 2000). The loss of ECM molecules 
from the native environment has been shown to be one of the limiting factors in graft success 
(Llacua et al., 2016; Nagata et al., 2001; Tatum et al., 2017). Perhaps establishing optimal 
bioreactor conditions for pre-culture of pancreatic islets with a hydrogel containing ECM 
molecules would improve the success of such a graft. Or maybe pre-culturing pancreatic islets 
with the recipients’ own endothelial cells under defined bioreactor conditions prior to 
implantation might improve both revascularisation of the graft and circumvent the host-
mediated immune response. However, more investigation of these bioreactor conditions is 
needed to achieve this goal.  
In summary, this thesis demonstrates that perfusion bioreactors offer stringent control of 
physiological parameters which may offer cells and/or tissue an environment closer to their 
native one and, therefore, influence cells to behave more natively. A number of different 
bioreactor conditions were tested and advantageous culture conditions for rat pancreata were 
identified. This knowledge could be applied to help improve the success and functionality of 
allogeneic islet grafts.   
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Appendix A 
Sterilisation Protocol: 
1.) Dismantle bioreactor of Whatman filters (#6713-1650), O-rings, and mass coriolis 
elements (picture 1). Wash all glass bottles (1x 2 L rinsing bottle, 1 x 5 L waste bottle, 
and 1 x 250 mL bottle) and jacketed vessel (after removing Whatman filter (#6713-1650) 
and large O-ring) and caps in Cidezyme® Enzymatic soap (15% v/v) (picture 2). Rinse 
thoroughly with distilled water and place in the dishwasher for 1h (heat cycle).   
2.) After, clean circuit tubing using a 50 mL syringe to create flow in the tubing. Then rinse 
thoroughly with distilled water. Remove all O-rings and repeat this procedure. After, 
spray 70% Ethanol over these bioreactor elements. 
3.) After, remove all bottles from the dishwasher and fill the 2 L rinsing bottle with 2L 
distilled water. Then add on the O-rings and caps to all the bottles. Then add the filters. 
Cover all filters with double layered aluminium foil and ensure they are secured with 
autoclave tape (so no moisture can enter them during the autoclave cycle (picture 3). 
4.) Place aluminium foil over the ends of the circuit tubing and secure this foil with 
autoclave tape (picture 3) 
5.) Remove and clean the stainless steel mass coriolis fittings and detachable pressure probe 
fitting (with O-ring) with Cidezyme® Enzymatic soap (15% v/v). After, rinse well with 
distilled water, dry, and then wrap in aluminium foil and place in a covered glass beaker 
(use autoclave to achieve cover) (picture 3) 
6.) Place all of the (now closed) bioreactor elements into an autoclavable holding box and 
put it into the autoclave. Here, you should select a liquid VAC cycle (minimum 15 mins 
at 121oC, 15lb psi pressure).  
7.) After, spray all elements thoroughly with 70% ethanol place all of the autoclaved pieces 
under a sterile laminar-flow hood in a Level-2 safety laboratory (picture 4). 
8.) Next, remove the autoclaved mass coriolis element and attach to the pressure transducer 
 110 
 
element under the laminar flow hood (picture 6). Next, spray all part with 70% ethanol 
and remove from the hood and attached to circuit tubing (picture 7). 
9.) Next, remove the autoclaved mass coriolis valves and spray with 70% ethanol and join 
them to the mass coriolis meter (picture 8). Then, attach the circuit tubing (picture 9) 
10.) Next, open the 3-way valves (magasine clinique #47254)  and filter (picture 10) and join 
them together in the same motif in picture 11.  
11.) Join the waste bottle and rinsing bottle to the valves and close the remaining exposed 
valves with red sterile stoppers (picture 12).  
12.) Next, stray with 70% ethanol and remove from hood. Quickly add these elements to the 
circuit tubing as shown in picture 13. 
13.) Next, fill 250 mL bottle with activated Cidex Plus® 28 day solution under the laminar 
flow hood. Close and spray with 70% ethanol. Incorporate into the bioreactor tubing 
(picture 14) under the laminar flow hood.  
14.) Attached bioreactor elements to the bottle and circulate solution overnight (minimum 
12h) (picture 15)  
15.) After, rinse with the autoclaved water in the sterile rinse bottle. Ensure the bioreactor 
system remains closed at all time to avoid contamination with air. 
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Appendix B 
 
Supplementary Figure 1. Positive immunofluorescence staining for Ki67 proliferation 
protein of INS-1 cells: 1. embedded in fibrin and cultured under perfusion bioreactor 
conditions for 48h and then exposed to the low-glucose concentration (2.8mM) for 24h, 2. 
cultured statically on TCPS for 48h, and after, exposed to a traditional GSIS, and 3. embedded 
in fibrin under static conditions for 48h and then exposed to a traditional GSIS. Nuclear 
staining was achieved using DAPI (blue). All experiments were performed in triplicate. The 
mean number of Ki67-positive cells (in Figure 7) was estimated by counting Ki67-positive 
cells in 40 fields of view for each condition.100× magnification. Scale bar represents 10µm. 
 
 
3D Fibrin, Static  Bioreactor, Low-Glucose  
TCPS, Static  
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Appendix C 
 
Comparison of a glucose-stimulated insulin secretion assay on mechanically-disrupted rat 
pancreata after 6h culture on TCPS plates in a traditional cell culture incubator using either 
Kreb’s Ringer Buffer Hepes (Kreb) or Pancreatic tissue medium (Med), containing 2.8 mM 
glucose (LG), 28 mM glucose (HG), HG + 50 µM IBMX. Each solution was incubated for 1 
h.  
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Time 0
Low Flow, High D.O., No Pulsation 
Low Flow, High D.O., Pulsation 
Static controls  
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Low Flow, Low D.O., Pulsation 
High Flow, High D.O., No Pulsation 
High Flow, High D.O., Pulsation 
Low Flow, Low D.O., No Pulsation 
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Hematoxylin and Eosin (H&E) staining of whole mechanically-disrupted rat pancreata 
cultured in supplemented medium (5.6 mM glucose) after 72h of culture under the respective 
bioreactor process conditions.. 
 
High Flow, Low D.O., Pulsation 
High Flow, Low D.O., No Pulsation 
